Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-590-3p AADAT 0.84 0.00129 -0.44 0.14671 miRanda; miRNATAP -0.2 0.00135 NA
2 hsa-miR-590-3p AASS 0.84 0.00129 -0.47 0.07736 MirTarget; miRanda -0.16 0.00457 NA
3 hsa-miR-590-3p ABAT 0.84 0.00129 -0.35 0.20779 PITA; miRanda -0.25 2.0E-5 NA
4 hsa-miR-181b-5p ABCA1 0.67 0.00024 -0.92 1.0E-5 miRNATAP -0.15 0.00295 NA
5 hsa-miR-361-5p ABCA1 0.21 0.0801 -0.92 1.0E-5 miRanda; mirMAP -0.17 0.0349 NA
6 hsa-miR-590-3p ABCA1 0.84 0.00129 -0.92 1.0E-5 miRanda -0.1 0.01762 NA
7 hsa-miR-590-3p ABCA10 0.84 0.00129 -1.84 0 miRanda; mirMAP -0.22 0.00395 NA
8 hsa-miR-590-3p ABCA13 0.84 0.00129 0.37 0.52362 miRanda; mirMAP -0.27 0.02716 NA
9 hsa-miR-590-3p ABCA6 0.84 0.00129 -1.98 0 MirTarget; miRanda -0.34 0 NA
10 hsa-miR-590-3p ABCA8 0.84 0.00129 -4.22 0 miRanda -0.64 0 NA
11 hsa-miR-590-3p ABCA9 0.84 0.00129 -2.24 0 miRanda -0.32 0 NA
12 hsa-miR-590-3p ABCB1 0.84 0.00129 -2.44 0 miRanda -0.17 0.01296 NA
13 hsa-miR-361-5p ABCC10 0.21 0.0801 0.67 0 miRanda -0.15 0.00218 NA
14 hsa-miR-590-3p ABCC3 0.84 0.00129 2.16 0 mirMAP -0.17 0.02116 NA
15 hsa-miR-590-3p ABCC4 0.84 0.00129 -0.61 0.02018 mirMAP -0.14 0.01488 NA
16 hsa-miR-590-3p ABCC9 0.84 0.00129 -1.69 0 miRanda; mirMAP -0.19 0.00172 NA
17 hsa-miR-590-3p ABCG2 0.84 0.00129 -2.65 0 miRanda; mirMAP -0.19 0.00236 NA
18 hsa-miR-590-3p ABHD12B 0.84 0.00129 -1.28 0.00196 miRanda; mirMAP; miRNATAP -0.22 0.01267 NA
19 hsa-miR-15a-5p ABHD13 1.63 0 -0.46 5.0E-5 MirTarget; miRNATAP -0.15 0 NA
20 hsa-miR-181b-5p ABHD13 0.67 0.00024 -0.46 5.0E-5 MirTarget -0.12 5.0E-5 NA
21 hsa-miR-590-3p ABHD2 0.84 0.00129 -0.74 0.00059 miRanda; mirMAP -0.16 0.00033 NA
22 hsa-miR-125a-5p ABHD3 -1.05 0 0.61 0.00031 PITA; miRanda -0.12 0.00174 NA
23 hsa-miR-590-3p ABI3BP 0.84 0.00129 -3.27 0 miRanda -0.32 9.0E-5 NA
24 hsa-miR-125a-5p ABL2 -1.05 0 0.31 0.01567 MirTarget; PITA -0.13 1.0E-5 26766902 MicroRNA 125a 5p modulates human cervical carcinoma proliferation and migration by targeting ABL2; The direct regulation of miR-125a-5p on its target gene ABL proto-oncogene 2 ABL2 in cervical carcinoma was evaluated by quantitative real-time reverse transcription polymerase chain reaction Western blotting and luciferase reporter assays respectively; ABL2 was shown to be directly targeted by miR-125a-5p; In cervical carcinoma ABL2 gene and protein levels were both downregulated by miR-125a-5p
25 hsa-miR-200c-3p ABL2 0.38 0.08422 0.31 0.01567 MirTarget -0.14 0 NA
26 hsa-miR-361-5p ABL2 0.21 0.0801 0.31 0.01567 mirMAP -0.11 0.02171 NA
27 hsa-miR-590-3p ABLIM1 0.84 0.00129 -1.2 0 miRanda; mirMAP -0.15 0.00271 NA
28 hsa-miR-590-3p ACADL 0.84 0.00129 -4.45 0 miRanda -0.42 0.00074 NA
29 hsa-miR-590-3p ACADSB 0.84 0.00129 -0.71 0.001 MirTarget; miRanda; mirMAP -0.23 0 NA
30 hsa-miR-181b-5p ACAP2 0.67 0.00024 -0.34 0.00833 MirTarget; miRNATAP -0.15 0 NA
31 hsa-miR-181b-5p ACER3 0.67 0.00024 -0.77 0 MirTarget -0.12 0.00047 NA
32 hsa-miR-15a-5p ACOX1 1.63 0 -0.01 0.90133 miRNATAP -0.12 8.0E-5 NA
33 hsa-miR-590-3p ACOX2 0.84 0.00129 -0.57 0.05834 miRanda -0.3 0 NA
34 hsa-miR-15a-5p ACSL4 1.63 0 -1.28 0 MirTarget; miRNATAP -0.31 0 NA
35 hsa-miR-181b-5p ACSL4 0.67 0.00024 -1.28 0 mirMAP -0.21 0.00017 NA
36 hsa-miR-590-3p ACSL4 0.84 0.00129 -1.28 0 MirTarget; PITA; miRanda; mirMAP -0.1 0.03134 NA
37 hsa-miR-590-3p ACSL5 0.84 0.00129 0.21 0.49172 miRanda; mirMAP -0.18 0.00436 NA
38 hsa-miR-590-3p ACSM5 0.84 0.00129 -1.96 0 miRanda -0.22 0.01346 NA
39 hsa-miR-181b-5p ACSS3 0.67 0.00024 -2.44 0 MirTarget -0.23 0.00972 NA
40 hsa-miR-590-3p ACSS3 0.84 0.00129 -2.44 0 miRanda -0.25 0.00066 NA
41 hsa-miR-125a-5p ACTBL2 -1.05 0 1.09 0.01994 miRanda -0.25 0.01538 NA
42 hsa-miR-590-3p ACTG2 0.84 0.00129 -2.01 0 miRanda -0.32 4.0E-5 NA
43 hsa-let-7a-3p ACTL6A 0.17 0.43183 0.81 0 MirTarget -0.13 0.00031 NA
44 hsa-miR-125a-5p ACTL6A -1.05 0 0.81 0 miRanda -0.23 0 NA
45 hsa-miR-15a-5p ACTR2 1.63 0 0.02 0.81607 MirTarget; miRNATAP -0.13 0 NA
46 hsa-let-7a-3p ACTR3 0.17 0.43183 0.28 0.01178 MirTarget; miRNATAP -0.12 2.0E-5 NA
47 hsa-miR-181b-5p ACVR1C 0.67 0.00024 0.52 0.12871 miRNATAP -0.18 0.03867 NA
48 hsa-miR-590-3p ACVR2A 0.84 0.00129 -0.18 0.16533 MirTarget; PITA; miRanda; miRNATAP -0.1 9.0E-5 NA
49 hsa-miR-125a-5p ADAM10 -1.05 0 -0.46 0.00434 miRanda -0.16 0 NA
50 hsa-miR-181b-5p ADAM22 0.67 0.00024 0.04 0.92539 mirMAP; miRNATAP -0.25 0.01024 NA
51 hsa-miR-590-3p ADAM33 0.84 0.00129 -2.04 0 miRanda -0.31 0.00012 NA
52 hsa-miR-125a-5p ADAM9 -1.05 0 0.21 0.29503 PITA; miRanda -0.15 0.00101 NA
53 hsa-miR-181b-5p ADAMTS1 0.67 0.00024 -2.65 0 miRNATAP -0.18 0.0127 NA
54 hsa-miR-590-3p ADAMTS1 0.84 0.00129 -2.65 0 miRanda -0.28 1.0E-5 NA
55 hsa-miR-590-3p ADAMTS17 0.84 0.00129 -1.08 0.00084 miRanda -0.34 0 NA
56 hsa-miR-15a-5p ADAMTS18 1.63 0 1.34 0.00247 miRNATAP -0.33 0.00249 NA
57 hsa-miR-181b-5p ADAMTS2 0.67 0.00024 -0.33 0.29024 mirMAP -0.2 0.0116 NA
58 hsa-miR-200c-3p ADAMTS3 0.38 0.08422 -0.48 0.13892 miRNATAP -0.23 0.00061 NA
59 hsa-miR-15a-5p ADAMTS5 1.63 0 -0.15 0.63547 miRNATAP -0.32 7.0E-5 NA
60 hsa-miR-181b-5p ADAMTS5 0.67 0.00024 -0.15 0.63547 mirMAP; miRNATAP -0.32 0.00011 NA
61 hsa-miR-590-3p ADAMTS8 0.84 0.00129 -4.68 0 miRanda -0.64 0 NA
62 hsa-miR-590-3p ADAMTS9 0.84 0.00129 -1.27 0 miRanda -0.14 0.01693 NA
63 hsa-miR-181b-5p ADAMTSL1 0.67 0.00024 -1.74 0 miRNATAP -0.25 0.00468 NA
64 hsa-miR-590-3p ADAMTSL1 0.84 0.00129 -1.74 0 miRanda; mirMAP -0.23 0.00252 NA
65 hsa-miR-15a-5p ADAMTSL3 1.63 0 -3.15 0 MirTarget -0.45 0 NA
66 hsa-miR-590-3p ADAMTSL3 0.84 0.00129 -3.15 0 miRanda -0.42 0 NA
67 hsa-miR-590-3p ADARB1 0.84 0.00129 -1.88 0 miRanda; mirMAP -0.24 0 NA
68 hsa-miR-590-3p ADCY2 0.84 0.00129 -1.12 0.01473 mirMAP -0.56 0 NA
69 hsa-miR-15a-5p ADCY5 1.63 0 -1.41 0.00306 MirTarget; miRNATAP -0.27 0.02021 NA
70 hsa-miR-590-3p ADCY6 0.84 0.00129 -0.15 0.33282 miRanda -0.11 0.00145 NA
71 hsa-miR-590-3p ADCY8 0.84 0.00129 -5.8 0 miRanda -0.32 0.00742 NA
72 hsa-miR-590-3p ADCY9 0.84 0.00129 -1.41 0 miRanda -0.33 0 NA
73 hsa-miR-590-3p ADCYAP1 0.84 0.00129 -1.16 0.01936 MirTarget; PITA; miRanda; miRNATAP -0.4 0.00014 NA
74 hsa-miR-590-3p ADD1 0.84 0.00129 -0.75 0 MirTarget; PITA; miRanda; miRNATAP -0.11 0 NA
75 hsa-miR-590-3p ADH1A 0.84 0.00129 -4.37 0 miRanda -0.59 0 NA
76 hsa-miR-590-3p ADH1B 0.84 0.00129 -4.94 0 miRanda; mirMAP -0.74 0 NA
77 hsa-miR-590-3p ADH6 0.84 0.00129 -1.02 0.10483 miRanda; mirMAP -0.27 0.04676 NA
78 hsa-miR-361-5p ADHFE1 0.21 0.0801 -1.21 0.00046 miRanda -0.35 0.00776 NA
79 hsa-miR-181b-5p ADM 0.67 0.00024 -0.33 0.31881 MirTarget; miRNATAP -0.28 0.00091 NA
80 hsa-miR-590-3p ADRB1 0.84 0.00129 -3.81 0 PITA; miRanda; mirMAP; miRNATAP -0.34 0.0011 NA
81 hsa-miR-15a-5p ADRB2 1.63 0 -3.46 0 MirTarget -0.19 0.03231 NA
82 hsa-miR-590-3p ADRB2 0.84 0.00129 -3.46 0 MirTarget; PITA; miRanda -0.37 0 NA
83 hsa-miR-590-3p AFF1 0.84 0.00129 -0.48 0.00026 MirTarget; PITA; miRanda; miRNATAP -0.14 0 NA
84 hsa-miR-590-3p AFF2 0.84 0.00129 -2.23 0 PITA; miRanda; mirMAP; miRNATAP -0.31 0.00129 NA
85 hsa-miR-590-3p AFF3 0.84 0.00129 -3.25 0 PITA; miRanda; mirMAP; miRNATAP -0.51 0 NA
86 hsa-miR-590-3p AFF4 0.84 0.00129 -0.15 0.22477 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.14 0 NA
87 hsa-miR-181b-5p AFG3L2 0.67 0.00024 0.09 0.43603 MirTarget; miRNATAP -0.1 0.00078 NA
88 hsa-miR-181b-5p AGFG1 0.67 0.00024 -0.11 0.35919 MirTarget; miRNATAP -0.18 0 NA
89 hsa-miR-181b-5p AGPAT4 0.67 0.00024 -1.4 0 mirMAP -0.14 0.01587 NA
90 hsa-miR-361-5p AGR2 0.21 0.0801 1.73 0.00012 miRanda -0.44 0.01219 NA
91 hsa-miR-590-3p AGTR1 0.84 0.00129 -2.83 0 miRanda -0.37 2.0E-5 NA
92 hsa-miR-590-3p AGTR2 0.84 0.00129 -5.08 0 PITA; miRanda -0.45 0.00781 NA
93 hsa-miR-361-5p AHCYL2 0.21 0.0801 -0.8 0.01305 miRanda -0.53 1.0E-5 NA
94 hsa-miR-590-3p AHNAK 0.84 0.00129 -2.28 0 miRanda -0.32 0 NA
95 hsa-miR-361-5p AK3 0.21 0.0801 -0.47 0.00019 miRanda -0.19 0.00012 NA
96 hsa-miR-590-3p AK7 0.84 0.00129 -1.68 1.0E-5 miRanda; mirMAP -0.2 0.01178 NA
97 hsa-miR-15a-5p AKAP11 1.63 0 -0.62 0 MirTarget; miRNATAP -0.17 0 NA
98 hsa-miR-361-5p AKAP11 0.21 0.0801 -0.62 0 mirMAP -0.11 0.02259 NA
99 hsa-miR-590-3p AKAP11 0.84 0.00129 -0.62 0 MirTarget; miRanda; miRNATAP -0.1 0.00013 NA
100 hsa-miR-590-3p AKAP13 0.84 0.00129 -1.2 0 PITA; miRanda; mirMAP -0.25 0 NA
101 hsa-miR-590-3p AKAP2 0.84 0.00129 -2.97 0 mirMAP -0.17 0.00386 NA
102 hsa-miR-590-3p AKAP6 0.84 0.00129 -0.99 0.00066 MirTarget; PITA; miRanda; mirMAP -0.17 0.00614 NA
103 hsa-miR-181b-5p AKR1C1 0.67 0.00024 -0.19 0.79967 mirMAP -0.94 0 NA
104 hsa-miR-15a-5p AKT3 1.63 0 -1.44 0 miRNAWalker2 validate; miRTarBase; miRNATAP -0.41 0 NA
105 hsa-miR-181b-5p AKT3 0.67 0.00024 -1.44 0 miRNATAP -0.37 0 NA
106 hsa-miR-590-3p ALCAM 0.84 0.00129 -0.7 0.00117 MirTarget; PITA; miRanda; mirMAP -0.15 0.00131 NA
107 hsa-miR-361-5p ALDH1L2 0.21 0.0801 0.4 0.18683 miRanda; mirMAP; miRNATAP -0.36 0.00215 NA
108 hsa-miR-590-3p ALDH3A2 0.84 0.00129 -0.45 0.06236 miRanda -0.16 0.00168 NA
109 hsa-miR-590-3p ALDH6A1 0.84 0.00129 -0.33 0.09417 miRanda -0.16 0.00016 NA
110 hsa-miR-590-3p ALDOB 0.84 0.00129 0.57 0.30252 miRanda -0.31 0.00742 NA
111 hsa-miR-361-5p ALG9 0.21 0.0801 0.13 0.25421 miRanda -0.11 0.01069 NA
112 hsa-miR-590-3p ALOX15B 0.84 0.00129 -2.01 4.0E-5 miRanda -0.48 0 NA
113 hsa-miR-590-3p ALOX5AP 0.84 0.00129 -2.35 0 miRanda -0.24 0.00013 NA
114 hsa-miR-590-3p AMIGO1 0.84 0.00129 -1.42 0 miRanda -0.24 0 NA
115 hsa-miR-590-3p AMOT 0.84 0.00129 -0.3 0.45043 mirMAP -0.21 0.0156 NA
116 hsa-miR-15a-5p AMOTL1 1.63 0 -2.04 0 MirTarget; miRNATAP -0.25 2.0E-5 NA
117 hsa-miR-590-3p AMOTL1 0.84 0.00129 -2.04 0 mirMAP -0.27 0 NA
118 hsa-miR-590-3p ANG 0.84 0.00129 -0.75 0.0061 miRanda -0.12 0.04539 NA
119 hsa-miR-590-3p ANGPT1 0.84 0.00129 -2.86 0 PITA; miRanda; mirMAP -0.4 0 NA
120 hsa-miR-125a-5p ANGPT2 -1.05 0 -0.36 0.23492 miRanda -0.23 0.0005 NA
121 hsa-miR-590-3p ANGPTL1 0.84 0.00129 -3.34 0 PITA; miRanda; mirMAP -0.29 0.00011 NA
122 hsa-miR-15a-5p ANK2 1.63 0 -1.34 2.0E-5 MirTarget; miRNATAP -0.26 0.00065 NA
123 hsa-miR-590-3p ANK2 0.84 0.00129 -1.34 2.0E-5 MirTarget; PITA; miRanda -0.25 0.00011 NA
124 hsa-miR-590-3p ANK3 0.84 0.00129 -1.32 0 MirTarget; PITA; miRanda; mirMAP -0.23 0.0001 NA
125 hsa-miR-590-3p ANKFN1 0.84 0.00129 -1.02 0.06121 miRanda -0.61 0 NA
126 hsa-miR-590-3p ANKFY1 0.84 0.00129 -0.55 0 PITA; miRanda; mirMAP; miRNATAP -0.12 0 NA
127 hsa-miR-200c-3p ANKH 0.38 0.08422 0 0.99073 miRNATAP -0.14 0.00072 NA
128 hsa-miR-590-3p ANKH 0.84 0.00129 0 0.99073 mirMAP; miRNATAP -0.1 0.01507 NA
129 hsa-miR-590-3p ANKHD1 0.84 0.00129 0.11 0.38304 miRanda -0.11 3.0E-5 NA
130 hsa-miR-361-5p ANKLE2 0.21 0.0801 0.26 0.03338 miRanda -0.13 0.00623 NA
131 hsa-miR-590-3p ANKMY1 0.84 0.00129 -0.2 0.2373 miRanda; mirMAP -0.13 0.00024 NA
132 hsa-miR-361-5p ANKRD16 0.21 0.0801 0.5 0.00047 miRanda -0.15 0.00699 NA
133 hsa-miR-590-3p ANKRD20A3 0.84 0.00129 -1.24 0.00022 miRanda; mirMAP -0.16 0.02485 NA
134 hsa-miR-125a-5p ANKRD26 -1.05 0 0.28 0.07053 miRanda -0.12 0.00037 NA
135 hsa-miR-181b-5p ANKRD27 0.67 0.00024 -0.15 0.22352 MirTarget -0.12 8.0E-5 NA
136 hsa-miR-590-3p ANKRD29 0.84 0.00129 -3.05 0 mirMAP -0.27 0.00335 NA
137 hsa-miR-361-5p ANKRD36B 0.21 0.0801 0.94 7.0E-5 miRanda -0.23 0.01056 NA
138 hsa-miR-590-3p ANKRD44 0.84 0.00129 -1.36 0 miRanda -0.16 0.0049 NA
139 hsa-miR-15a-5p ANKRD46 1.63 0 -0.38 0.01504 MirTarget -0.12 0.00255 NA
140 hsa-miR-590-3p ANKRD50 0.84 0.00129 -0.3 0.07201 PITA; miRanda; mirMAP -0.14 7.0E-5 NA
141 hsa-miR-15a-5p ANKS1A 1.63 0 -1.11 0 MirTarget -0.13 7.0E-5 NA
142 hsa-miR-590-3p ANKS1A 0.84 0.00129 -1.11 0 PITA; miRanda -0.15 0 NA
143 hsa-miR-200c-3p ANLN 0.38 0.08422 3.51 0 MirTarget; miRNATAP -0.18 0.02457 NA
144 hsa-miR-590-3p ANO1 0.84 0.00129 -0.71 0.02851 miRanda -0.21 0.002 NA
145 hsa-miR-590-3p ANO2 0.84 0.00129 -2.81 0 miRanda -0.29 2.0E-5 NA
146 hsa-miR-15a-5p ANO3 1.63 0 -0.9 0.06994 MirTarget; miRNATAP -0.32 0.00996 NA
147 hsa-miR-361-5p ANO3 0.21 0.0801 -0.9 0.06994 miRanda -0.52 0.00641 NA
148 hsa-miR-590-3p ANO4 0.84 0.00129 -1.09 0.02542 miRanda -0.35 0.00077 NA
149 hsa-miR-590-3p ANO5 0.84 0.00129 -1.91 2.0E-5 miRanda; mirMAP -0.35 0.00026 NA
150 hsa-miR-590-3p ANO6 0.84 0.00129 -1.11 0 MirTarget; miRanda; mirMAP -0.14 1.0E-5 NA
NumGOOverlapSizeP ValueAdj. P Value
1 CARDIOVASCULAR SYSTEM DEVELOPMENT 250 788 3.068e-36 7.138e-33
2 CIRCULATORY SYSTEM DEVELOPMENT 250 788 3.068e-36 7.138e-33
3 CELL DEVELOPMENT 376 1426 2.165e-34 3.358e-31
4 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 420 1672 2.484e-33 2.89e-30
5 TISSUE DEVELOPMENT 388 1518 2.168e-32 2.018e-29
6 NEUROGENESIS 365 1402 3.89e-32 3.017e-29
7 REGULATION OF CELL DIFFERENTIATION 380 1492 2.341e-31 1.556e-28
8 VASCULATURE DEVELOPMENT 164 469 2.702e-29 1.572e-26
9 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 303 1142 4.211e-28 2.177e-25
10 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 273 1021 6.936e-26 3.227e-23
11 BIOLOGICAL ADHESION 274 1032 1.809e-25 7.654e-23
12 NEURON DIFFERENTIATION 242 874 2.854e-25 1.106e-22
13 BLOOD VESSEL MORPHOGENESIS 131 364 6.151e-25 2.202e-22
14 REGULATION OF CELLULAR COMPONENT MOVEMENT 219 771 1.745e-24 5.801e-22
15 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 163 513 6.317e-24 1.959e-21
16 CELLULAR COMPONENT MORPHOGENESIS 243 900 1.032e-23 3.001e-21
17 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 313 1275 6.147e-23 1.682e-20
18 POSITIVE REGULATION OF CELL DIFFERENTIATION 225 823 9.351e-23 2.417e-20
19 HEART DEVELOPMENT 149 466 2.93e-22 7.175e-20
20 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 250 957 3.199e-22 7.442e-20
21 RESPONSE TO ENDOGENOUS STIMULUS 343 1450 3.405e-22 7.545e-20
22 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 331 1395 1.205e-21 2.548e-19
23 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 258 1008 1.389e-21 2.811e-19
24 EPITHELIUM DEVELOPMENT 244 945 5.597e-21 1.085e-18
25 REGULATION OF CELL DEVELOPMENT 222 836 9.556e-21 1.779e-18
26 POSITIVE REGULATION OF MOLECULAR FUNCTION 398 1791 1.921e-20 3.438e-18
27 ORGAN MORPHOGENESIS 222 841 2.108e-20 3.634e-18
28 CELL PROJECTION ORGANIZATION 232 902 9.353e-20 1.554e-17
29 POSITIVE REGULATION OF GENE EXPRESSION 384 1733 1.724e-19 2.766e-17
30 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 189 689 2.026e-19 3.142e-17
31 LOCOMOTION 271 1114 2.51e-19 3.768e-17
32 NEURON PROJECTION DEVELOPMENT 159 545 3.027e-19 4.338e-17
33 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 392 1784 3.077e-19 4.338e-17
34 NEURON DEVELOPMENT 188 687 3.356e-19 4.593e-17
35 REGULATION OF PHOSPHORUS METABOLIC PROCESS 360 1618 1.43e-18 1.902e-16
36 REGULATION OF NEURON DIFFERENTIATION 159 554 1.691e-18 2.186e-16
37 CENTRAL NERVOUS SYSTEM DEVELOPMENT 222 872 2.251e-18 2.831e-16
38 HEAD DEVELOPMENT 190 709 2.456e-18 3.008e-16
39 EMBRYO DEVELOPMENT 225 894 5.586e-18 6.465e-16
40 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 398 1848 5.696e-18 6.465e-16
41 REGULATION OF CELL PROLIFERATION 336 1496 5.454e-18 6.465e-16
42 NEURON PROJECTION MORPHOGENESIS 125 402 9.013e-18 9.985e-16
43 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 196 750 1.303e-17 1.41e-15
44 REGULATION OF HYDROLASE ACTIVITY 304 1327 1.446e-17 1.53e-15
45 TUBE DEVELOPMENT 156 552 1.713e-17 1.733e-15
46 ANGIOGENESIS 100 293 1.703e-17 1.733e-15
47 TISSUE MORPHOGENESIS 152 533 1.847e-17 1.829e-15
48 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 116 368 4.457e-17 4.321e-15
49 POSITIVE REGULATION OF CATALYTIC ACTIVITY 334 1518 1.691e-16 1.606e-14
50 REGULATION OF TRANSPORT 384 1804 1.74e-16 1.619e-14
51 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 384 1805 1.907e-16 1.74e-14
52 POSITIVE REGULATION OF HYDROLASE ACTIVITY 222 905 2.136e-16 1.911e-14
53 REGULATION OF GTPASE ACTIVITY 177 673 2.717e-16 2.385e-14
54 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 239 1004 6.012e-16 5.18e-14
55 CELL PART MORPHOGENESIS 168 633 6.504e-16 5.502e-14
56 RESPONSE TO GROWTH FACTOR 136 475 6.665e-16 5.538e-14
57 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 355 1656 9.955e-16 8.126e-14
58 INTRACELLULAR SIGNAL TRANSDUCTION 340 1572 1.185e-15 9.506e-14
59 REGULATION OF CELL MORPHOGENESIS 151 552 1.266e-15 9.984e-14
60 MUSCLE STRUCTURE DEVELOPMENT 126 432 1.711e-15 1.327e-13
61 UROGENITAL SYSTEM DEVELOPMENT 97 299 2.188e-15 1.669e-13
62 CELL MOTILITY 205 835 2.964e-15 2.189e-13
63 LOCALIZATION OF CELL 205 835 2.964e-15 2.189e-13
64 POSITIVE REGULATION OF LOCOMOTION 122 420 6.72e-15 4.886e-13
65 REGULATION OF PROTEIN MODIFICATION PROCESS 360 1710 9.733e-15 6.967e-13
66 STEM CELL DIFFERENTIATION 70 190 1.533e-14 1.081e-12
67 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 230 983 1.654e-14 1.149e-12
68 RESPONSE TO OXYGEN CONTAINING COMPOUND 301 1381 2.306e-14 1.578e-12
69 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 195 799 2.714e-14 1.83e-12
70 POSITIVE REGULATION OF CELL COMMUNICATION 327 1532 2.948e-14 1.96e-12
71 FOREBRAIN DEVELOPMENT 107 357 3.284e-14 2.152e-12
72 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 195 801 3.514e-14 2.271e-12
73 EMBRYONIC MORPHOGENESIS 144 539 4.661e-14 2.971e-12
74 ACTIN FILAMENT BASED PROCESS 126 450 4.819e-14 3.03e-12
75 RESPONSE TO ORGANIC CYCLIC COMPOUND 216 917 5.339e-14 3.312e-12
76 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 295 1360 8.094e-14 4.955e-12
77 POSITIVE REGULATION OF NEURON DIFFERENTIATION 95 306 8.806e-14 5.321e-12
78 SKELETAL SYSTEM DEVELOPMENT 126 455 1.157e-13 6.904e-12
79 POSITIVE REGULATION OF CELL DEVELOPMENT 129 472 1.684e-13 9.918e-12
80 SYNAPSE ORGANIZATION 57 145 1.748e-13 1.017e-11
81 RESPONSE TO WOUNDING 147 563 1.845e-13 1.06e-11
82 REGULATION OF NEURON PROJECTION DEVELOPMENT 115 408 3.824e-13 2.17e-11
83 REGULATION OF CELL PROJECTION ORGANIZATION 145 558 4.039e-13 2.264e-11
84 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 234 1036 5.24e-13 2.835e-11
85 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 234 1036 5.24e-13 2.835e-11
86 RESPONSE TO HORMONE 208 893 5.162e-13 2.835e-11
87 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 76 229 6.375e-13 3.371e-11
88 PROTEIN PHOSPHORYLATION 217 944 6.338e-13 3.371e-11
89 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 120 437 8.398e-13 4.39e-11
90 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 132 498 1.006e-12 5.204e-11
91 NEGATIVE REGULATION OF CELL PROLIFERATION 160 643 1.166e-12 5.964e-11
92 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 76 232 1.342e-12 6.789e-11
93 TELENCEPHALON DEVELOPMENT 75 228 1.491e-12 7.462e-11
94 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 91 303 2.397e-12 1.186e-10
95 REGULATION OF EPITHELIAL CELL PROLIFERATION 87 285 2.726e-12 1.335e-10
96 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 311 1492 2.954e-12 1.403e-10
97 POSITIVE REGULATION OF TRANSPORT 213 936 2.937e-12 1.403e-10
98 EXTRACELLULAR STRUCTURE ORGANIZATION 91 304 2.942e-12 1.403e-10
99 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 251 1152 4.265e-12 2.005e-10
100 REGULATION OF VASCULATURE DEVELOPMENT 75 233 4.996e-12 2.325e-10
101 POSITIVE REGULATION OF RESPONSE TO STIMULUS 384 1929 5.115e-12 2.357e-10
102 RESPONSE TO LIPID 203 888 6.322e-12 2.884e-10
103 REGULATION OF HEART CONTRACTION 72 221 6.98e-12 3.153e-10
104 BEHAVIOR 133 516 7.161e-12 3.204e-10
105 POSITIVE REGULATION OF CELL PROLIFERATION 189 814 8.461e-12 3.749e-10
106 REGULATION OF SYSTEM PROCESS 131 507 8.596e-12 3.773e-10
107 REGULATION OF EPITHELIAL CELL MIGRATION 59 166 9.999e-12 4.348e-10
108 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 390 1977 1.227e-11 5.287e-10
109 MUSCLE CELL DIFFERENTIATION 75 237 1.267e-11 5.408e-10
110 MESENCHYMAL CELL DIFFERENTIATION 51 134 1.358e-11 5.746e-10
111 REGULATION OF ACTIN FILAMENT BASED PROCESS 91 312 1.442e-11 6.045e-10
112 REGULATION OF KINASE ACTIVITY 181 776 1.589e-11 6.601e-10
113 MUSCLE TISSUE DEVELOPMENT 83 275 1.655e-11 6.815e-10
114 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 174 740 1.987e-11 8.111e-10
115 NEGATIVE REGULATION OF CELL COMMUNICATION 255 1192 2.136e-11 8.568e-10
116 REGULATION OF BLOOD CIRCULATION 87 295 2.121e-11 8.568e-10
117 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 136 541 2.785e-11 1.098e-09
118 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 136 541 2.785e-11 1.098e-09
119 TAXIS 121 464 2.844e-11 1.112e-09
120 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 83 278 3.065e-11 1.188e-09
121 REGULATION OF GROWTH 153 633 3.925e-11 1.497e-09
122 RESPIRATORY SYSTEM DEVELOPMENT 65 197 3.905e-11 1.497e-09
123 REGULATION OF DEVELOPMENTAL GROWTH 85 289 4.198e-11 1.585e-09
124 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 95 337 4.225e-11 1.585e-09
125 VASCULOGENESIS 30 59 4.647e-11 1.73e-09
126 CELL CELL ADHESION 148 608 4.767e-11 1.76e-09
127 REGULATION OF MEMBRANE POTENTIAL 96 343 5.172e-11 1.895e-09
128 MESENCHYME DEVELOPMENT 63 190 6.141e-11 2.232e-09
129 ION TRANSPORT 265 1262 6.487e-11 2.34e-09
130 REGULATION OF BODY FLUID LEVELS 128 506 6.89e-11 2.466e-09
131 MORPHOGENESIS OF AN EPITHELIUM 107 400 8.022e-11 2.849e-09
132 RESPONSE TO STEROID HORMONE 126 497 8.328e-11 2.936e-09
133 REGULATION OF CELL ADHESION 151 629 8.999e-11 3.148e-09
134 REGULATION OF ION TRANSPORT 144 592 9.245e-11 3.21e-09
135 SENSORY ORGAN DEVELOPMENT 125 493 9.824e-11 3.386e-09
136 RESPONSE TO NITROGEN COMPOUND 193 859 1.033e-10 3.534e-09
137 EPITHELIAL CELL DIFFERENTIATION 125 495 1.301e-10 4.42e-09
138 KIDNEY EPITHELIUM DEVELOPMENT 47 125 1.384e-10 4.665e-09
139 CHEMICAL HOMEOSTASIS 195 874 1.541e-10 5.158e-09
140 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 241 1135 1.692e-10 5.625e-09
141 REGULATION OF TRANSMEMBRANE TRANSPORT 111 426 1.976e-10 6.522e-09
142 EMBRYONIC ORGAN DEVELOPMENT 107 406 2.061e-10 6.707e-09
143 NEGATIVE REGULATION OF CELL DIFFERENTIATION 146 609 2.054e-10 6.707e-09
144 CIRCULATORY SYSTEM PROCESS 99 366 2.098e-10 6.779e-09
145 CELLULAR RESPONSE TO HORMONE STIMULUS 135 552 2.449e-10 7.859e-09
146 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 41 103 2.671e-10 8.441e-09
147 REGULATION OF CELL DEATH 298 1472 2.685e-10 8.441e-09
148 TUBE MORPHOGENESIS 90 323 2.655e-10 8.441e-09
149 REGULATION OF MAPK CASCADE 155 660 2.824e-10 8.819e-09
150 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 135 554 3.169e-10 9.829e-09
151 POSITIVE REGULATION OF KINASE ACTIVITY 121 482 3.82e-10 1.177e-08
152 RESPONSE TO OXYGEN LEVELS 87 311 4.229e-10 1.295e-08
153 NEGATIVE REGULATION OF PHOSPHORYLATION 109 422 4.977e-10 1.514e-08
154 RESPONSE TO ALCOHOL 97 362 5.533e-10 1.672e-08
155 WOUND HEALING 118 470 6.266e-10 1.881e-08
156 SECOND MESSENGER MEDIATED SIGNALING 54 160 6.736e-10 1.984e-08
157 HOMEOSTATIC PROCESS 273 1337 6.714e-10 1.984e-08
158 ARTERY DEVELOPMENT 33 75 6.71e-10 1.984e-08
159 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 39 98 7.301e-10 2.136e-08
160 NEURON PROJECTION GUIDANCE 64 205 7.375e-10 2.145e-08
161 SINGLE ORGANISM BEHAVIOR 101 384 7.44e-10 2.15e-08
162 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 76 262 8.939e-10 2.567e-08
163 CARDIAC MUSCLE TISSUE DEVELOPMENT 49 140 1.013e-09 2.893e-08
164 RESPONSE TO INORGANIC SUBSTANCE 119 479 1.05e-09 2.978e-08
165 SPROUTING ANGIOGENESIS 24 45 1.134e-09 3.198e-08
166 NEGATIVE REGULATION OF CELL DEVELOPMENT 84 303 1.358e-09 3.788e-08
167 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 52 154 1.359e-09 3.788e-08
168 CELL FATE COMMITMENT 68 227 1.558e-09 4.315e-08
169 RESPONSE TO ABIOTIC STIMULUS 217 1024 1.745e-09 4.805e-08
170 PALATE DEVELOPMENT 35 85 1.825e-09 4.995e-08
171 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 52 156 2.272e-09 6.183e-08
172 EYE DEVELOPMENT 88 326 2.341e-09 6.332e-08
173 NEGATIVE REGULATION OF LOCOMOTION 75 263 2.652e-09 7.133e-08
174 REGULATION OF ENDOTHELIAL CELL MIGRATION 42 114 2.674e-09 7.151e-08
175 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 63 207 3.087e-09 8.207e-08
176 RESPONSE TO CALCIUM ION 42 115 3.627e-09 9.588e-08
177 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 30 68 3.68e-09 9.673e-08
178 CELLULAR RESPONSE TO NITROGEN COMPOUND 122 505 3.941e-09 1.03e-07
179 PHOSPHORYLATION 250 1228 4.975e-09 1.293e-07
180 SYNAPSE ASSEMBLY 30 69 5.611e-09 1.45e-07
181 CARTILAGE DEVELOPMENT 49 147 6.52e-09 1.676e-07
182 REGULATION OF ANATOMICAL STRUCTURE SIZE 115 472 6.604e-09 1.679e-07
183 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 102 404 6.601e-09 1.679e-07
184 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 53 166 8.77e-09 2.218e-07
185 CONNECTIVE TISSUE DEVELOPMENT 59 194 9.954e-09 2.492e-07
186 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 62 208 9.962e-09 2.492e-07
187 POSITIVE REGULATION OF MAPK CASCADE 114 470 1.004e-08 2.498e-07
188 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 26 56 1.078e-08 2.669e-07
189 MULTICELLULAR ORGANISMAL SIGNALING 43 123 1.091e-08 2.687e-07
190 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 29 67 1.137e-08 2.785e-07
191 REGULATION OF CELLULAR COMPONENT BIOGENESIS 168 767 1.201e-08 2.926e-07
192 REGULATION OF CELLULAR LOCALIZATION 256 1277 1.397e-08 3.384e-07
193 CELLULAR RESPONSE TO LIPID 111 457 1.446e-08 3.487e-07
194 GROWTH 102 410 1.504e-08 3.607e-07
195 REGULATION OF CELL SUBSTRATE ADHESION 54 173 1.538e-08 3.67e-07
196 REGULATION OF HOMEOSTATIC PROCESS 109 447 1.555e-08 3.693e-07
197 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 45 133 1.59e-08 3.755e-07
198 CYTOSKELETON ORGANIZATION 180 838 1.627e-08 3.823e-07
199 REGULATION OF OSSIFICATION 55 178 1.688e-08 3.946e-07
200 CYCLIC NUCLEOTIDE METABOLIC PROCESS 26 57 1.71e-08 3.979e-07
201 PATTERN SPECIFICATION PROCESS 103 418 2.174e-08 5.033e-07
202 HEART MORPHOGENESIS 62 212 2.204e-08 5.076e-07
203 CAMP METABOLIC PROCESS 19 34 2.242e-08 5.139e-07
204 REPRODUCTIVE SYSTEM DEVELOPMENT 101 408 2.317e-08 5.284e-07
205 OSSIFICATION 70 251 2.404e-08 5.457e-07
206 CAMERA TYPE EYE MORPHOGENESIS 37 101 2.76e-08 6.215e-07
207 TRANSMEMBRANE TRANSPORT 224 1098 2.765e-08 6.215e-07
208 CARDIAC SEPTUM DEVELOPMENT 33 85 2.991e-08 6.69e-07
209 GLAND DEVELOPMENT 98 395 3.317e-08 7.357e-07
210 DEVELOPMENTAL GROWTH 86 333 3.321e-08 7.357e-07
211 AMEBOIDAL TYPE CELL MIGRATION 49 154 3.558e-08 7.833e-07
212 RHYTHMIC PROCESS 79 298 3.569e-08 7.833e-07
213 REGULATION OF TRANSFERASE ACTIVITY 197 946 4.092e-08 8.939e-07
214 ENDOTHELIUM DEVELOPMENT 34 90 4.132e-08 8.943e-07
215 NEPHRON DEVELOPMENT 40 115 4.119e-08 8.943e-07
216 REGULATION OF PHOSPHATASE ACTIVITY 43 128 4.165e-08 8.972e-07
217 REGULATION OF MUSCLE ORGAN DEVELOPMENT 37 103 5.015e-08 1.075e-06
218 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 45 138 5.607e-08 1.197e-06
219 REGULATION OF PROTEIN LOCALIZATION 197 950 5.684e-08 1.208e-06
220 REGULATION OF TRANSPORTER ACTIVITY 58 198 5.814e-08 1.23e-06
221 CELL CELL SIGNALING 165 767 5.87e-08 1.23e-06
222 GLOMERULUS DEVELOPMENT 23 49 5.864e-08 1.23e-06
223 CATION TRANSPORT 170 796 6.198e-08 1.293e-06
224 REGULATION OF CHEMOTAXIS 54 180 6.873e-08 1.428e-06
225 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 110 465 7.436e-08 1.538e-06
226 ORGAN GROWTH 28 68 7.492e-08 1.543e-06
227 REGULATION OF WOUND HEALING 42 126 7.649e-08 1.568e-06
228 NEGATIVE REGULATION OF GENE EXPRESSION 288 1493 7.699e-08 1.571e-06
229 PALLIUM DEVELOPMENT 48 153 7.968e-08 1.619e-06
230 EPITHELIAL CELL DEVELOPMENT 55 186 8.949e-08 1.798e-06
231 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 15 24 8.964e-08 1.798e-06
232 CEREBRAL CORTEX DEVELOPMENT 37 105 8.919e-08 1.798e-06
233 REGULATION OF METAL ION TRANSPORT 83 325 9.701e-08 1.937e-06
234 RESPONSE TO KETONE 54 182 1.032e-07 2.051e-06
235 STRIATED MUSCLE CELL DIFFERENTIATION 52 173 1.113e-07 2.205e-06
236 NEGATIVE REGULATION OF CELL DEATH 182 872 1.158e-07 2.284e-06
237 IN UTERO EMBRYONIC DEVELOPMENT 80 311 1.185e-07 2.326e-06
238 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 11 14 1.383e-07 2.705e-06
239 MESONEPHROS DEVELOPMENT 33 90 1.492e-07 2.904e-06
240 MUSCLE ORGAN DEVELOPMENT 73 277 1.5e-07 2.908e-06
241 REGULATION OF HEART RATE 32 86 1.546e-07 2.986e-06
242 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 28 70 1.563e-07 3.005e-06
243 RESPONSE TO ACID CHEMICAL 81 319 1.79e-07 3.427e-06
244 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 136 616 1.857e-07 3.542e-06
245 ACTIVATION OF PROTEIN KINASE ACTIVITY 73 279 2.038e-07 3.871e-06
246 REGULATION OF CARTILAGE DEVELOPMENT 26 63 2.058e-07 3.894e-06
247 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 49 162 2.069e-07 3.897e-06
248 LOCOMOTORY BEHAVIOR 53 181 2.157e-07 4.046e-06
249 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 55 191 2.359e-07 4.407e-06
250 OVULATION CYCLE 38 113 2.424e-07 4.51e-06
251 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 133 602 2.433e-07 4.51e-06
252 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 109 470 2.476e-07 4.572e-06
253 REGULATION OF CYTOPLASMIC TRANSPORT 111 481 2.512e-07 4.62e-06
254 CARDIOCYTE DIFFERENTIATION 34 96 2.551e-07 4.673e-06
255 EPITHELIAL TO MESENCHYMAL TRANSITION 24 56 2.581e-07 4.692e-06
256 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 181 876 2.579e-07 4.692e-06
257 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 217 1087 2.629e-07 4.76e-06
258 SEX DIFFERENTIATION 70 266 2.843e-07 5.127e-06
259 EYE MORPHOGENESIS 43 136 2.909e-07 5.226e-06
260 RESPONSE TO METAL ION 83 333 2.962e-07 5.302e-06
261 REGULATION OF PHOSPHOLIPASE ACTIVITY 26 64 2.991e-07 5.332e-06
262 METAL ION TRANSPORT 129 582 3.053e-07 5.402e-06
263 IMMUNE SYSTEM DEVELOPMENT 129 582 3.053e-07 5.402e-06
264 MUSCLE SYSTEM PROCESS 73 282 3.2e-07 5.64e-06
265 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 23 53 3.478e-07 6.106e-06
266 ACTIN FILAMENT ORGANIZATION 51 174 3.505e-07 6.131e-06
267 POST EMBRYONIC DEVELOPMENT 32 89 3.844e-07 6.698e-06
268 DIVALENT INORGANIC CATION TRANSPORT 70 268 3.86e-07 6.702e-06
269 POSITIVE REGULATION OF GROWTH 64 238 3.966e-07 6.86e-06
270 RENAL SYSTEM PROCESS 35 102 4.121e-07 7.101e-06
271 INOSITOL LIPID MEDIATED SIGNALING 40 124 4.14e-07 7.108e-06
272 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 57 204 4.333e-07 7.413e-06
273 PANCREAS DEVELOPMENT 28 73 4.393e-07 7.488e-06
274 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 11 15 4.503e-07 7.647e-06
275 SENSORY ORGAN MORPHOGENESIS 64 239 4.66e-07 7.885e-06
276 EAR DEVELOPMENT 55 195 4.931e-07 8.313e-06
277 CELL PROLIFERATION 144 672 5.214e-07 8.758e-06
278 REGULATION OF MUSCLE TISSUE DEVELOPMENT 35 103 5.379e-07 9.002e-06
279 ION TRANSMEMBRANE TRANSPORT 170 822 5.64e-07 9.405e-06
280 CARDIAC CONDUCTION 30 82 5.722e-07 9.509e-06
281 REGULATION OF CELL GROWTH 93 391 5.748e-07 9.517e-06
282 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 34 99 5.863e-07 9.572e-06
283 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 34 99 5.863e-07 9.572e-06
284 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 46 153 5.826e-07 9.572e-06
285 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 34 99 5.863e-07 9.572e-06
286 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 25 62 5.961e-07 9.698e-06
287 CARDIAC CHAMBER DEVELOPMENT 44 144 6.199e-07 1.004e-05
288 REGULATION OF DEPHOSPHORYLATION 47 158 6.215e-07 1.004e-05
289 ARTERY MORPHOGENESIS 22 51 7.071e-07 1.138e-05
290 RETINA DEVELOPMENT IN CAMERA TYPE EYE 41 131 7.349e-07 1.179e-05
291 REGULATION OF MAP KINASE ACTIVITY 79 319 7.465e-07 1.194e-05
292 REGULATION OF POTASSIUM ION TRANSPORT 30 83 7.727e-07 1.231e-05
293 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 14 24 8.122e-07 1.29e-05
294 CARDIAC MUSCLE CELL ACTION POTENTIAL 18 37 8.327e-07 1.318e-05
295 EMBRYONIC ORGAN MORPHOGENESIS 71 279 9.181e-07 1.448e-05
296 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 133 616 9.236e-07 1.452e-05
297 POSITIVE REGULATION OF CELL DEATH 131 605 9.485e-07 1.486e-05
298 REGULATION OF COAGULATION 31 88 9.716e-07 1.512e-05
299 OVULATION CYCLE PROCESS 31 88 9.716e-07 1.512e-05
300 REGULATION OF MESENCHYMAL CELL PROLIFERATION 17 34 1.029e-06 1.596e-05
301 LUNG ALVEOLUS DEVELOPMENT 19 41 1.063e-06 1.644e-05
302 REGULATION OF HORMONE LEVELS 108 478 1.072e-06 1.651e-05
303 ENDOTHELIAL CELL DIFFERENTIATION 27 72 1.184e-06 1.818e-05
304 NEPHRON EPITHELIUM DEVELOPMENT 32 93 1.188e-06 1.818e-05
305 RESPONSE TO MECHANICAL STIMULUS 57 210 1.21e-06 1.846e-05
306 POSITIVE REGULATION OF CELL ADHESION 89 376 1.24e-06 1.886e-05
307 CELLULAR RESPONSE TO OXYGEN LEVELS 43 143 1.335e-06 2.012e-05
308 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 36 111 1.333e-06 2.012e-05
309 POSITIVE REGULATION OF CHEMOTAXIS 38 120 1.336e-06 2.012e-05
310 REGULATION OF ION HOMEOSTASIS 55 201 1.405e-06 2.109e-05
311 MORPHOGENESIS OF A BRANCHING STRUCTURE 48 167 1.424e-06 2.13e-05
312 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 58 216 1.431e-06 2.135e-05
313 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 15 28 1.441e-06 2.143e-05
314 SINGLE ORGANISM CELL ADHESION 104 459 1.471e-06 2.179e-05
315 FEMALE SEX DIFFERENTIATION 37 116 1.506e-06 2.225e-05
316 ACTION POTENTIAL 32 94 1.552e-06 2.286e-05
317 SECRETION 127 588 1.588e-06 2.332e-05
318 REGULATION OF ORGAN GROWTH 27 73 1.621e-06 2.372e-05
319 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 38 121 1.678e-06 2.447e-05
320 REGULATION OF OSTEOBLAST DIFFERENTIATION 36 112 1.693e-06 2.462e-05
321 REGULATION OF WNT SIGNALING PATHWAY 76 310 1.812e-06 2.626e-05
322 REGULATION OF CELLULAR COMPONENT SIZE 81 337 1.947e-06 2.809e-05
323 REPRODUCTION 247 1297 1.95e-06 2.809e-05
324 REGULATION OF RESPONSE TO WOUNDING 95 413 2.091e-06 3.003e-05
325 DIVALENT INORGANIC CATION HOMEOSTASIS 82 343 2.116e-06 3.025e-05
326 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 34 104 2.119e-06 3.025e-05
327 RESPONSE TO EXTERNAL STIMULUS 332 1821 2.172e-06 3.091e-05
328 CARDIAC MUSCLE CELL DIFFERENTIATION 27 74 2.202e-06 3.124e-05
329 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 73 296 2.277e-06 3.212e-05
330 VENTRICULAR SEPTUM DEVELOPMENT 22 54 2.278e-06 3.212e-05
331 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 42 141 2.312e-06 3.251e-05
332 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 150 724 2.354e-06 3.29e-05
333 NEGATIVE REGULATION OF WOUND HEALING 23 58 2.355e-06 3.29e-05
334 REGULATION OF INTRACELLULAR TRANSPORT 132 621 2.413e-06 3.361e-05
335 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 15 29 2.585e-06 3.58e-05
336 CARDIAC MUSCLE CELL CONTRACTION 15 29 2.585e-06 3.58e-05
337 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 52 190 2.672e-06 3.689e-05
338 POSITIVE REGULATION OF ENDOCYTOSIS 36 114 2.698e-06 3.703e-05
339 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 58 220 2.698e-06 3.703e-05
340 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 282 1517 2.823e-06 3.863e-05
341 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 107 482 2.845e-06 3.871e-05
342 MUSCLE CELL DEVELOPMENT 39 128 2.845e-06 3.871e-05
343 COGNITION 64 251 2.884e-06 3.912e-05
344 NEURAL CREST CELL DIFFERENTIATION 27 75 2.969e-06 4.015e-05
345 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 184 926 2.977e-06 4.015e-05
346 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 61 236 3.039e-06 4.076e-05
347 RESPONSE TO CORTICOSTEROID 49 176 3.031e-06 4.076e-05
348 REGULATION OF STEM CELL PROLIFERATION 30 88 3.151e-06 4.213e-05
349 CELL ACTIVATION 122 568 3.384e-06 4.512e-05
350 DIGESTIVE SYSTEM DEVELOPMENT 43 148 3.621e-06 4.814e-05
351 CELLULAR RESPONSE TO PEPTIDE 68 274 3.957e-06 5.246e-05
352 HEMOSTASIS 75 311 4.039e-06 5.339e-05
353 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 42 144 4.196e-06 5.53e-05
354 SMOOTHENED SIGNALING PATHWAY 26 72 4.216e-06 5.542e-05
355 CALCIUM ION TRANSPORT 58 223 4.268e-06 5.594e-05
356 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 20 48 4.322e-06 5.649e-05
357 SMOOTH MUSCLE CELL DIFFERENTIATION 15 30 4.477e-06 5.835e-05
358 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 37 121 4.609e-06 5.991e-05
359 RESPONSE TO PEPTIDE 92 404 4.676e-06 6.044e-05
360 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 23 60 4.667e-06 6.044e-05
361 REGULATION OF SECRETION 144 699 5.139e-06 6.606e-05
362 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 50 184 5.132e-06 6.606e-05
363 DEVELOPMENTAL CELL GROWTH 27 77 5.279e-06 6.767e-05
364 REGULATION OF CELL MATRIX ADHESION 30 90 5.304e-06 6.78e-05
365 WNT SIGNALING PATHWAY 82 351 5.467e-06 6.969e-05
366 RETINA MORPHOGENESIS IN CAMERA TYPE EYE 19 45 5.918e-06 7.524e-05
367 CELLULAR RESPONSE TO ACID CHEMICAL 48 175 5.956e-06 7.551e-05
368 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 13 24 6.26e-06 7.915e-05
369 ANION TRANSPORT 110 507 6.297e-06 7.938e-05
370 CELLULAR RESPONSE TO CALCIUM ION 20 49 6.312e-06 7.938e-05
371 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 23 61 6.47e-06 8.114e-05
372 ENDOTHELIAL CELL MIGRATION 22 57 6.563e-06 8.197e-05
373 BONE DEVELOPMENT 44 156 6.571e-06 8.197e-05
374 REGULATION OF ORGAN MORPHOGENESIS 61 242 7.21e-06 8.97e-05
375 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 59 232 7.544e-06 9.36e-05
376 REGULATION OF HEART GROWTH 18 42 8.061e-06 9.975e-05
377 CELLULAR HOMEOSTASIS 139 676 8.261e-06 0.000102
378 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 19 46 8.718e-06 0.000107
379 REGULATION OF CHONDROCYTE DIFFERENTIATION 19 46 8.718e-06 0.000107
380 MONOSACCHARIDE TRANSPORT 21 54 9.219e-06 0.0001129
381 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 35 115 9.254e-06 0.000113
382 CARDIAC VENTRICLE DEVELOPMENT 33 106 9.703e-06 0.0001182
383 REGULATION OF CELLULAR PROTEIN LOCALIZATION 117 552 1.02e-05 0.0001239
384 TISSUE MIGRATION 28 84 1.079e-05 0.0001304
385 POSITIVE REGULATION OF OSSIFICATION 28 84 1.079e-05 0.0001304
386 ACTIN FILAMENT BASED MOVEMENT 30 93 1.112e-05 0.0001341
387 REGULATION OF CYTOSKELETON ORGANIZATION 108 502 1.125e-05 0.0001353
388 CELL SUBSTRATE ADHESION 45 164 1.135e-05 0.0001361
389 REGULATION OF VASCULOGENESIS 9 13 1.142e-05 0.0001367
390 CELL GROWTH 39 135 1.166e-05 0.0001391
391 SECRETION BY CELL 105 486 1.227e-05 0.000146
392 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 19 47 1.265e-05 0.0001495
393 REGULATION OF BINDING 68 283 1.266e-05 0.0001495
394 POSITIVE REGULATION OF DEPHOSPHORYLATION 19 47 1.265e-05 0.0001495
395 REGULATION OF MUSCLE SYSTEM PROCESS 51 195 1.334e-05 0.0001571
396 CELL JUNCTION ORGANIZATION 49 185 1.354e-05 0.0001587
397 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 38 131 1.353e-05 0.0001587
398 GLOMERULAR EPITHELIUM DEVELOPMENT 11 19 1.418e-05 0.0001658
399 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 16 36 1.464e-05 0.0001708
400 REGIONALIZATION 73 311 1.471e-05 0.0001711
401 METANEPHROS DEVELOPMENT 27 81 1.541e-05 0.0001788
402 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 14 29 1.569e-05 0.0001816
403 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 22 60 1.717e-05 0.0001982
404 CELLULAR CHEMICAL HOMEOSTASIS 119 570 1.781e-05 0.0002051
405 CELL DEATH 192 1001 1.803e-05 0.0002071
406 NEGATIVE REGULATION OF COAGULATION 19 48 1.811e-05 0.0002076
407 ION HOMEOSTASIS 120 576 1.818e-05 0.0002079
408 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 31 100 1.96e-05 0.0002235
409 LEUKOCYTE DIFFERENTIATION 69 292 1.975e-05 0.0002241
410 MULTI MULTICELLULAR ORGANISM PROCESS 54 213 1.975e-05 0.0002241
411 REGULATED EXOCYTOSIS 56 224 2.161e-05 0.0002447
412 REGULATION OF PROTEIN IMPORT 48 183 2.174e-05 0.0002456
413 RENAL TUBULE DEVELOPMENT 26 78 2.2e-05 0.0002477
414 REGULATION OF AXONOGENESIS 45 168 2.204e-05 0.0002477
415 REGULATION OF MEMBRANE LIPID DISTRIBUTION 16 37 2.234e-05 0.0002499
416 CAMP MEDIATED SIGNALING 16 37 2.234e-05 0.0002499
417 NEURON MIGRATION 33 110 2.289e-05 0.0002548
418 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 33 110 2.289e-05 0.0002548
419 CELL JUNCTION ASSEMBLY 37 129 2.3e-05 0.0002554
420 REGULATION OF PEPTIDE SECRETION 53 209 2.327e-05 0.0002579
421 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 95 437 2.424e-05 0.0002679
422 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 40 144 2.495e-05 0.0002751
423 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 14 30 2.55e-05 0.0002778
424 REGULATION OF LIPASE ACTIVITY 27 83 2.537e-05 0.0002778
425 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 19 49 2.559e-05 0.0002778
426 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 14 30 2.55e-05 0.0002778
427 CARDIAC SEPTUM MORPHOGENESIS 19 49 2.559e-05 0.0002778
428 REGULATION OF DENDRITE DEVELOPMENT 35 120 2.561e-05 0.0002778
429 CARDIAC CELL DEVELOPMENT 19 49 2.559e-05 0.0002778
430 AMMONIUM ION METABOLIC PROCESS 45 169 2.587e-05 0.0002787
431 APPENDAGE DEVELOPMENT 45 169 2.587e-05 0.0002787
432 LIMB DEVELOPMENT 45 169 2.587e-05 0.0002787
433 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 68 289 2.614e-05 0.0002809
434 MELANOCYTE DIFFERENTIATION 11 20 2.738e-05 0.0002935
435 REGULATION OF CATION CHANNEL ACTIVITY 28 88 2.863e-05 0.0003062
436 FOREBRAIN GENERATION OF NEURONS 23 66 2.889e-05 0.0003069
437 POSITIVE REGULATION OF LIPASE ACTIVITY 23 66 2.889e-05 0.0003069
438 REGULATION OF CARDIAC CONDUCTION 23 66 2.889e-05 0.0003069
439 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 15 34 3.016e-05 0.0003175
440 RESPONSE TO FLUID SHEAR STRESS 15 34 3.016e-05 0.0003175
441 RENAL WATER HOMEOSTASIS 15 34 3.016e-05 0.0003175
442 MODULATION OF SYNAPTIC TRANSMISSION 70 301 3.007e-05 0.0003175
443 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 31 102 3.023e-05 0.0003175
444 FOREBRAIN CELL MIGRATION 22 62 3.108e-05 0.0003257
445 AMINOGLYCAN BIOSYNTHETIC PROCESS 32 107 3.24e-05 0.000338
446 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 108 514 3.236e-05 0.000338
447 POSITIVE REGULATION OF HEART GROWTH 13 27 3.282e-05 0.0003409
448 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 13 27 3.282e-05 0.0003409
449 EMBRYONIC PATTERN SPECIFICATION 21 58 3.305e-05 0.0003425
450 POSITIVE REGULATION OF ORGAN GROWTH 16 38 3.341e-05 0.0003455
451 RESPONSE TO REACTIVE OXYGEN SPECIES 49 191 3.365e-05 0.0003472
452 NEGATIVE REGULATION OF TRANSPORT 98 458 3.524e-05 0.0003628
453 REGENERATION 43 161 3.576e-05 0.0003667
454 MUSCLE CONTRACTION 57 233 3.578e-05 0.0003667
455 REGULATION OF RECEPTOR ACTIVITY 34 117 3.608e-05 0.000369
456 VESICLE MEDIATED TRANSPORT 229 1239 3.741e-05 0.0003817
457 POSITIVE REGULATION OF BINDING 36 127 3.884e-05 0.0003955
458 REGULATION OF CALCIUM MEDIATED SIGNALING 25 76 4.046e-05 0.0004111
459 HEART PROCESS 27 85 4.082e-05 0.0004138
460 REGULATION OF MUSCLE CONTRACTION 40 147 4.173e-05 0.0004222
461 MESODERM DEVELOPMENT 34 118 4.371e-05 0.0004412
462 REGULATION OF PEPTIDE TRANSPORT 61 256 4.486e-05 0.0004518
463 AXIS SPECIFICATION 28 90 4.517e-05 0.000453
464 CALCIUM MEDIATED SIGNALING 28 90 4.517e-05 0.000453
465 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 20 55 4.708e-05 0.0004711
466 REGULATION OF HORMONE SECRETION 62 262 4.852e-05 0.0004845
467 REGULATION OF PHOSPHOLIPASE C ACTIVITY 16 39 4.907e-05 0.0004858
468 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 16 39 4.907e-05 0.0004858
469 ASTROCYTE DIFFERENTIATION 16 39 4.907e-05 0.0004858
470 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 16 39 4.907e-05 0.0004858
471 REGULATION OF CELL JUNCTION ASSEMBLY 23 68 4.962e-05 0.0004902
472 LIPID TRANSLOCATION 11 21 4.995e-05 0.0004924
473 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 17 43 5.054e-05 0.0004972
474 REGULATION OF EMBRYONIC DEVELOPMENT 33 114 5.081e-05 0.0004988
475 ANTERIOR POSTERIOR PATTERN SPECIFICATION 49 194 5.178e-05 0.0005061
476 REGULATION OF BMP SIGNALING PATHWAY 25 77 5.175e-05 0.0005061
477 POSITIVE REGULATION OF ION TRANSPORT 57 236 5.256e-05 0.0005127
478 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 30 100 5.286e-05 0.0005146
479 VENTRICULAR SEPTUM MORPHOGENESIS 13 28 5.315e-05 0.0005152
480 MUSCLE HYPERTROPHY 13 28 5.315e-05 0.0005152
481 ENSHEATHMENT OF NEURONS 28 91 5.632e-05 0.0005437
482 AXON ENSHEATHMENT 28 91 5.632e-05 0.0005437
483 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 10 18 5.743e-05 0.0005523
484 REGULATION OF CELL SHAPE 38 139 5.745e-05 0.0005523
485 CELLULAR RESPONSE TO KETONE 24 73 5.786e-05 0.0005551
486 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 21 60 5.899e-05 0.0005648
487 CELLULAR RESPONSE TO ALCOHOL 33 115 6.147e-05 0.0005873
488 ENDOCARDIAL CUSHION DEVELOPMENT 14 32 6.213e-05 0.0005924
489 LEUKOCYTE MIGRATION 61 259 6.43e-05 0.0006118
490 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 25 78 6.578e-05 0.0006246
491 SKELETAL SYSTEM MORPHOGENESIS 50 201 6.653e-05 0.0006305
492 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 12 25 6.881e-05 0.0006482
493 DOPAMINE METABOLIC PROCESS 12 25 6.881e-05 0.0006482
494 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 12 25 6.881e-05 0.0006482
495 ENDOCRINE PANCREAS DEVELOPMENT 16 40 7.084e-05 0.0006659
496 EMBRYONIC PLACENTA DEVELOPMENT 26 83 7.324e-05 0.000687
497 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 65 282 7.527e-05 0.0007047
498 POSITIVE REGULATION OF STEM CELL PROLIFERATION 21 61 7.778e-05 0.0007268
499 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 53 218 7.858e-05 0.0007313
500 PROTEIN COMPLEX SUBUNIT ORGANIZATION 273 1527 7.847e-05 0.0007313
501 NEGATIVE REGULATION OF KINASE ACTIVITY 59 250 7.906e-05 0.0007342
502 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 41 156 7.953e-05 0.0007372
503 PROTEIN LOCALIZATION TO CELL PERIPHERY 40 151 8.006e-05 0.0007396
504 ESTABLISHMENT OF CELL POLARITY 27 88 8.011e-05 0.0007396
505 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 79 360 8.144e-05 0.0007503
506 NEURAL PRECURSOR CELL PROLIFERATION 23 70 8.277e-05 0.0007612
507 ERBB SIGNALING PATHWAY 25 79 8.312e-05 0.0007629
508 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 135 684 8.445e-05 0.0007735
509 PLASMA MEMBRANE ORGANIZATION 50 203 8.704e-05 0.0007957
510 MAMMARY GLAND DEVELOPMENT 33 117 8.904e-05 0.0008124
511 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 19 53 9.047e-05 0.0008238
512 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 34 122 9.112e-05 0.0008265
513 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 34 122 9.112e-05 0.0008265
514 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 26 84 9.16e-05 0.0008278
515 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 42 162 9.163e-05 0.0008278
516 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 22 66 9.208e-05 0.0008287
517 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 22 66 9.208e-05 0.0008287
518 NEGATIVE REGULATION OF ION TRANSPORT 35 127 9.267e-05 0.0008324
519 NEURON RECOGNITION 14 33 9.357e-05 0.0008381
520 REGULATION OF MUSCLE CELL DIFFERENTIATION 40 152 9.366e-05 0.0008381
521 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 24 75 9.399e-05 0.0008394
522 CORONARY VASCULATURE DEVELOPMENT 15 37 9.902e-05 0.000881
523 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 15 37 9.902e-05 0.000881
524 EPITHELIAL CELL PROLIFERATION 27 89 9.93e-05 0.0008817
525 REGULATION OF MEMBRANE DEPOLARIZATION 16 41 0.0001006 0.0008902
526 AORTA DEVELOPMENT 16 41 0.0001006 0.0008902
527 NEGATIVE REGULATION OF GROWTH 56 236 0.0001014 0.0008957
528 REGULATION OF SYNAPSE ORGANIZATION 32 113 0.000104 0.000913
529 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 63 274 0.0001038 0.000913
530 REGULATION OF STEM CELL DIFFERENTIATION 32 113 0.000104 0.000913
531 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 10 19 0.0001055 0.0009243
532 VASCULAR PROCESS IN CIRCULATORY SYSTEM 42 163 0.0001064 0.0009305
533 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 33 118 0.0001066 0.0009309
534 ENDOCRINE SYSTEM DEVELOPMENT 34 123 0.0001086 0.0009465
535 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 12 26 0.000111 0.0009634
536 RESPONSE TO OXIDATIVE STRESS 77 352 0.0001108 0.0009634
537 LIPID PHOSPHORYLATION 29 99 0.0001121 0.0009714
538 LIPID LOCALIZATION 61 264 0.0001145 0.0009901
539 POSITIVE REGULATION OF PROTEIN IMPORT 30 104 0.0001172 0.001012
540 EXTRACELLULAR MATRIX ASSEMBLY 9 16 0.0001208 0.001037
541 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 82 381 0.0001204 0.001037
542 NEURON CELL CELL ADHESION 9 16 0.0001208 0.001037
543 RESPONSE TO HYDROGEN PEROXIDE 31 109 0.0001214 0.00104
544 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 51 211 0.0001241 0.001061
545 REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING 8 13 0.000125 0.001068
546 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 13 30 0.000128 0.001089
547 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 13 30 0.000128 0.001089
548 NEURAL RETINA DEVELOPMENT 18 50 0.0001293 0.001098
549 CARBOHYDRATE TRANSPORT 28 95 0.0001299 0.001099
550 CANONICAL WNT SIGNALING PATHWAY 28 95 0.0001299 0.001099
551 FOREBRAIN NEURON DEVELOPMENT 14 34 0.000138 0.001163
552 CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS 14 34 0.000138 0.001163
553 CATECHOLAMINE METABOLIC PROCESS 16 42 0.0001408 0.001181
554 REGULATION OF BONE REMODELING 16 42 0.0001408 0.001181
555 CATECHOL CONTAINING COMPOUND METABOLIC PROCESS 16 42 0.0001408 0.001181
556 COLLAGEN FIBRIL ORGANIZATION 15 38 0.0001418 0.001185
557 ODONTOGENESIS 30 105 0.0001416 0.001185
558 INNERVATION 11 23 0.0001447 0.001206
559 NEGATIVE REGULATION OF CELL ADHESION 53 223 0.0001468 0.001222
560 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 40 155 0.000148 0.001229
561 RESPONSE TO ESTROGEN 52 218 0.000153 0.001267
562 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 52 218 0.000153 0.001267
563 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 48 197 0.0001574 0.001301
564 KIDNEY MORPHOGENESIS 25 82 0.0001622 0.001338
565 REGULATION OF NEURON APOPTOTIC PROCESS 47 192 0.000163 0.001342
566 AMINOGLYCAN METABOLIC PROCESS 42 166 0.0001645 0.001352
567 POSITIVE REGULATION OF PROTEIN BINDING 23 73 0.0001696 0.001391
568 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 21 64 0.0001698 0.001391
569 RESPONSE TO FIBROBLAST GROWTH FACTOR 32 116 0.0001777 0.001451
570 CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT 32 116 0.0001777 0.001451
571 LEUKOCYTE ACTIVATION 87 414 0.0001805 0.001471
572 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 35 131 0.0001809 0.001472
573 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 10 20 0.0001836 0.001491
574 CELLULAR RESPONSE TO STRESS 276 1565 0.0001843 0.001494
575 REGULATION OF PROTEIN TARGETING 68 307 0.0001849 0.001496
576 REGULATION OF CALCIUM ION TRANSPORT 50 209 0.0001878 0.001517
577 STEM CELL PROLIFERATION 20 60 0.0001892 0.00152
578 CHONDROCYTE DIFFERENTIATION 20 60 0.0001892 0.00152
579 NEGATIVE REGULATION OF MOLECULAR FUNCTION 198 1079 0.0001886 0.00152
580 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 13 31 0.0001913 0.001535
581 POSITIVE REGULATION OF AXONOGENESIS 22 69 0.0001922 0.00154
582 ACTIVATION OF ADENYLATE CYCLASE ACTIVITY 15 39 0.0001998 0.001584
583 REGULATION OF AXON GUIDANCE 15 39 0.0001998 0.001584
584 LONG TERM SYNAPTIC POTENTIATION 15 39 0.0001998 0.001584
585 COCHLEA DEVELOPMENT 15 39 0.0001998 0.001584
586 RESPONSE TO MINERALOCORTICOID 14 35 0.0001994 0.001584
587 NEGATIVE CHEMOTAXIS 15 39 0.0001998 0.001584
588 REGULATION OF ENDOCYTOSIS 48 199 0.0002033 0.001609
589 PLATELET DEGRANULATION 30 107 0.0002045 0.001616
590 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 79 370 0.0002072 0.001634
591 SMAD PROTEIN SIGNAL TRANSDUCTION 19 56 0.0002092 0.001647
592 REGULATION OF VESICLE MEDIATED TRANSPORT 95 462 0.0002119 0.001665
593 REGULATION OF DENDRITE MORPHOGENESIS 23 74 0.0002127 0.001666
594 REGULATION OF ACUTE INFLAMMATORY RESPONSE 23 74 0.0002127 0.001666
595 POSITIVE REGULATION OF HEMOPOIESIS 41 163 0.0002236 0.001737
596 NEGATIVE REGULATION OF PLATELET ACTIVATION 9 17 0.0002236 0.001737
597 CAMP BIOSYNTHETIC PROCESS 9 17 0.0002236 0.001737
598 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 9 17 0.0002236 0.001737
599 ACTIVATION OF PROTEIN KINASE A ACTIVITY 9 17 0.0002236 0.001737
600 ACTIVATION OF MAPKK ACTIVITY 18 52 0.0002291 0.001777
601 DENDRITE DEVELOPMENT 24 79 0.0002309 0.001786
602 REGULATION OF POSITIVE CHEMOTAXIS 11 24 0.0002322 0.001786
603 POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 11 24 0.0002322 0.001786
604 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 11 24 0.0002322 0.001786
605 REGULATION OF ODONTOGENESIS 11 24 0.0002322 0.001786
606 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 85 406 0.000242 0.001858
607 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 22 70 0.0002424 0.001858
608 MEMBRANE DEPOLARIZATION 20 61 0.0002435 0.001864
609 REGULATION OF PROTEIN SECRETION 82 389 0.0002454 0.001875
610 POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 17 48 0.000248 0.00188
611 DIGESTIVE TRACT MORPHOGENESIS 17 48 0.000248 0.00188
612 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 25 84 0.0002467 0.00188
613 ANTERIOR POSTERIOR AXIS SPECIFICATION 17 48 0.000248 0.00188
614 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 17 48 0.000248 0.00188
615 EXOCYTOSIS 68 310 0.0002487 0.001882
616 T CELL DIFFERENTIATION 33 123 0.0002507 0.001894
617 VOCALIZATION BEHAVIOR 8 14 0.0002546 0.001911
618 REGULATION OF GLOMERULUS DEVELOPMENT 8 14 0.0002546 0.001911
619 CAMP CATABOLIC PROCESS 8 14 0.0002546 0.001911
620 POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY 8 14 0.0002546 0.001911
621 OLFACTORY BULB INTERNEURON DEVELOPMENT 7 11 0.0002565 0.001922
622 REGULATION OF JNK CASCADE 40 159 0.000264 0.001975
623 ENDOMEMBRANE SYSTEM ORGANIZATION 95 465 0.0002683 0.002004
624 CELL CYCLE ARREST 39 154 0.0002705 0.002017
625 MULTICELLULAR ORGANISMAL HOMEOSTASIS 61 272 0.000272 0.002025
626 MESODERM MORPHOGENESIS 21 66 0.0002752 0.002043
627 LENS DEVELOPMENT IN CAMERA TYPE EYE 21 66 0.0002752 0.002043
628 GLIOGENESIS 43 175 0.0002769 0.002052
629 POSITIVE REGULATION OF MAP KINASE ACTIVITY 49 207 0.0002826 0.00209
630 NEUROMUSCULAR JUNCTION DEVELOPMENT 14 36 0.0002831 0.002091
631 RESPONSE TO ORGANOPHOSPHORUS 36 139 0.0002866 0.002113
632 INTERACTION WITH HOST 35 134 0.0002904 0.002138
633 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 30 109 0.0002912 0.00214
634 MESONEPHRIC TUBULE MORPHOGENESIS 18 53 0.0003004 0.002205
635 ANION TRANSMEMBRANE TRANSPORT 57 251 0.0003028 0.002219
636 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 10 21 0.0003051 0.002232
637 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 23 76 0.0003288 0.002402
638 ORGANIC ANION TRANSPORT 81 387 0.0003373 0.00246
639 ADULT BEHAVIOR 35 135 0.0003382 0.002463
640 GLYCOPROTEIN METABOLIC PROCESS 75 353 0.000345 0.002508
641 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 21 67 0.0003468 0.002517
642 ENDOCHONDRAL BONE MORPHOGENESIS 16 45 0.0003559 0.00258
643 REGULATION OF ACTIN FILAMENT LENGTH 39 156 0.0003584 0.002594
644 DEVELOPMENTAL MATURATION 46 193 0.0003626 0.00262
645 ALCOHOL METABOLIC PROCESS 74 348 0.0003667 0.002645
646 PIGMENTATION 25 86 0.000368 0.00265
647 REGULATION OF CELL SIZE 42 172 0.0003729 0.002682
648 CELLULAR RESPONSE TO INSULIN STIMULUS 37 146 0.0003772 0.002709
649 PROTEIN LOCALIZATION 311 1805 0.0003831 0.002747
650 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 9 18 0.0003898 0.002773
651 ORGANONITROGEN COMPOUND CATABOLIC PROCESS 73 343 0.0003896 0.002773
652 GLANDULAR EPITHELIAL CELL DEVELOPMENT 9 18 0.0003898 0.002773
653 PERICARDIUM DEVELOPMENT 9 18 0.0003898 0.002773
654 INOSITOL PHOSPHATE MEDIATED SIGNALING 9 18 0.0003898 0.002773
655 REGULATION OF THE FORCE OF HEART CONTRACTION 12 29 0.000391 0.002773
656 PIGMENT CELL DIFFERENTIATION 12 29 0.000391 0.002773
657 NEUROEPITHELIAL CELL DIFFERENTIATION 20 63 0.0003944 0.002793
658 AXON EXTENSION 14 37 0.0003952 0.002795
659 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 13 33 0.0004008 0.002826
660 EMBRYONIC EYE MORPHOGENESIS 13 33 0.0004008 0.002826
661 SPINAL CORD DEVELOPMENT 29 106 0.0004064 0.002861
662 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 31 116 0.0004093 0.002877
663 CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS 116 595 0.0004229 0.002967
664 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 38 152 0.0004234 0.002967
665 SIGNAL RELEASE 42 173 0.0004246 0.002971
666 MYELOID CELL DIFFERENTIATION 45 189 0.0004275 0.002987
667 REGULATION OF ADHERENS JUNCTION ORGANIZATION 17 50 0.0004319 0.003013
668 NERVE DEVELOPMENT 21 68 0.0004341 0.003023
669 REGULATION OF PROTEIN BINDING 41 168 0.0004403 0.003062
670 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 25 87 0.0004462 0.003072
671 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 25 87 0.0004462 0.003072
672 VIRAL ENTRY INTO HOST CELL 25 87 0.0004462 0.003072
673 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 25 87 0.0004462 0.003072
674 MOVEMENT IN HOST ENVIRONMENT 25 87 0.0004462 0.003072
675 ENTRY INTO HOST 25 87 0.0004462 0.003072
676 ENTRY INTO HOST CELL 25 87 0.0004462 0.003072
677 CELLULAR MACROMOLECULE LOCALIZATION 220 1234 0.0004584 0.003151
678 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 26 92 0.0004604 0.00316
679 REGULATION OF ORGANELLE ORGANIZATION 211 1178 0.0004634 0.003176
680 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 22 73 0.0004683 0.003205
681 GLAND MORPHOGENESIS 27 97 0.0004708 0.003214
682 RESPONSE TO PURINE CONTAINING COMPOUND 39 158 0.000471 0.003214
683 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 16 46 0.0004731 0.003223
684 REGULATION OF CELL CYCLE 174 949 0.0004745 0.003228
685 OLFACTORY BULB INTERNEURON DIFFERENTIATION 8 15 0.0004763 0.003231
686 NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 8 15 0.0004763 0.003231
687 RESPONSE TO RETINOIC ACID 29 107 0.0004814 0.003261
688 CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 10 22 0.0004869 0.003293
689 REGULATION OF BLOOD PRESSURE 41 169 0.0005013 0.003385
690 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 18 55 0.0005023 0.003387
691 DENDRITE MORPHOGENESIS 15 42 0.0005113 0.003443
692 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 74 352 0.00052 0.003496
693 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 34 133 0.000538 0.003607
694 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 34 133 0.000538 0.003607
695 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 21 69 0.0005399 0.003614
696 PHOSPHOLIPID METABOLIC PROCESS 76 364 0.0005444 0.003618
697 REGULATION OF ACTION POTENTIAL 14 38 0.000543 0.003618
698 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 11 26 0.0005436 0.003618
699 HEART GROWTH 11 26 0.0005436 0.003618
700 MESENCHYME MORPHOGENESIS 14 38 0.000543 0.003618
701 HEPATICOBILIARY SYSTEM DEVELOPMENT 33 128 0.0005481 0.003638
702 NEURON MATURATION 12 30 0.0005663 0.003738
703 REGULATION OF SMOOTH MUSCLE CONTRACTION 19 60 0.0005655 0.003738
704 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 12 30 0.0005663 0.003738
705 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 19 60 0.0005655 0.003738
706 MUCOPOLYSACCHARIDE METABOLIC PROCESS 29 108 0.0005684 0.003746
707 NEURAL TUBE DEVELOPMENT 37 149 0.0005741 0.003779
708 ACTIN MEDIATED CELL CONTRACTION 22 74 0.0005765 0.003789
709 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 46 197 0.0005855 0.003842
710 SODIUM ION TRANSPORT 36 144 0.0005911 0.003874
711 INORGANIC ION TRANSMEMBRANE TRANSPORT 113 583 0.0006222 0.004072
712 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 57 258 0.0006263 0.004088
713 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 47 203 0.0006264 0.004088
714 MEMBRANE ORGANIZATION 165 899 0.0006278 0.004091
715 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 24 84 0.00063 0.004094
716 CYTOKINESIS 24 84 0.00063 0.004094
717 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 33 129 0.0006358 0.004121
718 GASTRULATION 38 155 0.0006359 0.004121
719 REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 9 19 0.0006456 0.004138
720 KIDNEY VASCULATURE DEVELOPMENT 9 19 0.0006456 0.004138
721 REGULATION OF DENDRITIC SPINE DEVELOPMENT 18 56 0.0006412 0.004138
722 SYNAPTIC SIGNALING 86 424 0.0006454 0.004138
723 ENTEROENDOCRINE CELL DIFFERENTIATION 9 19 0.0006456 0.004138
724 RENAL SYSTEM VASCULATURE DEVELOPMENT 9 19 0.0006456 0.004138
725 OUTFLOW TRACT MORPHOGENESIS 18 56 0.0006412 0.004138
726 ASTROCYTE DEVELOPMENT 9 19 0.0006456 0.004138
727 CELL PROJECTION ASSEMBLY 58 264 0.0006532 0.004181
728 CELL MATRIX ADHESION 31 119 0.0006573 0.004201
729 RESPONSE TO BMP 26 94 0.0006598 0.004205
730 CELLULAR RESPONSE TO BMP STIMULUS 26 94 0.0006598 0.004205
731 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 27 99 0.000667 0.004246
732 POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 29 109 0.0006689 0.004252
733 CARDIAC CHAMBER MORPHOGENESIS 28 104 0.0006699 0.004253
734 CEREBRAL CORTEX CELL MIGRATION 15 43 0.0006811 0.004317
735 CELLULAR LIPID METABOLIC PROCESS 167 913 0.0006843 0.004332
736 REGULATION OF SYNAPTIC PLASTICITY 35 140 0.0006987 0.004417
737 RESPONSE TO DRUG 87 431 0.0007047 0.004443
738 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 22 75 0.0007057 0.004443
739 MULTI ORGANISM BEHAVIOR 22 75 0.0007057 0.004443
740 POSITIVE REGULATION OF CYCLASE ACTIVITY 19 61 0.0007112 0.004472
741 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 34 135 0.0007178 0.004501
742 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 34 135 0.0007178 0.004501
743 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 41 172 0.0007318 0.004583
744 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 23 80 0.0007361 0.004597
745 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 14 39 0.0007352 0.004597
746 REGULATION OF MYELOID CELL DIFFERENTIATION 43 183 0.0007566 0.004719
747 IMMUNE SYSTEM PROCESS 336 1984 0.0007589 0.004721
748 ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS 24 85 0.000759 0.004721
749 REGULATION OF CARDIAC MUSCLE CONTRACTION 20 66 0.0007708 0.004789
750 REGULATION OF OXIDOREDUCTASE ACTIVITY 25 90 0.0007751 0.004809
751 MICROTUBULE BASED MOVEMENT 47 205 0.0007848 0.004862
752 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 11 27 0.000798 0.004899
753 CELL PROLIFERATION IN FOREBRAIN 11 27 0.000798 0.004899
754 MOTOR NEURON AXON GUIDANCE 11 27 0.000798 0.004899
755 REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 11 27 0.000798 0.004899
756 POSITIVE REGULATION OF RESPONSE TO WOUNDING 39 162 0.0007941 0.004899
757 REGULATION OF CATENIN IMPORT INTO NUCLEUS 11 27 0.000798 0.004899
758 AXIS ELONGATION 11 27 0.000798 0.004899
759 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 16 48 0.0008086 0.004957
760 NEGATIVE REGULATION OF CELL CYCLE 87 433 0.000818 0.005008
761 GLIAL CELL DIFFERENTIATION 34 136 0.0008261 0.005051
762 POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 8 16 0.0008319 0.005067
763 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 8 16 0.0008319 0.005067
764 REGULATION OF DEVELOPMENTAL PIGMENTATION 8 16 0.0008319 0.005067
765 LEARNING 33 131 0.0008488 0.005163
766 OSTEOBLAST DIFFERENTIATION 32 126 0.0008697 0.005283
767 PHENOL CONTAINING COMPOUND METABOLIC PROCESS 23 81 0.0008891 0.005387
768 REGULATION OF TISSUE REMODELING 19 62 0.000888 0.005387
769 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 15 44 0.0008964 0.005424
770 PROTEIN DEPHOSPHORYLATION 44 190 0.0009113 0.005507
771 REGULATION OF FAT CELL DIFFERENTIATION 28 106 0.0009266 0.005592
772 REGULATION OF EXTENT OF CELL GROWTH 27 101 0.0009312 0.005613
773 POSITIVE REGULATION OF CELL MATRIX ADHESION 14 40 0.0009819 0.005903
774 DEVELOPMENTAL PIGMENTATION 14 40 0.0009819 0.005903
775 REGULATION OF HEMOPOIESIS 66 314 0.001013 0.006066
776 POSITIVE REGULATION OF CELL GROWTH 36 148 0.001013 0.006066
777 MALE SEX DIFFERENTIATION 36 148 0.001013 0.006066
778 TYPE B PANCREATIC CELL DEVELOPMENT 7 13 0.001021 0.006076
779 VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 7 13 0.001021 0.006076
780 TRACHEA DEVELOPMENT 9 20 0.001024 0.006076
781 NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE 7 13 0.001021 0.006076
782 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 63 297 0.001023 0.006076
783 LIPID METABOLIC PROCESS 205 1158 0.001022 0.006076
784 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 7 13 0.001021 0.006076
785 ACTIN FILAMENT BUNDLE ORGANIZATION 16 49 0.001041 0.006148
786 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 22 77 0.001041 0.006148
787 DIENCEPHALON DEVELOPMENT 22 77 0.001041 0.006148
788 SPHINGOLIPID BIOSYNTHETIC PROCESS 22 77 0.001041 0.006148
789 NEGATIVE REGULATION OF BLOOD CIRCULATION 13 36 0.001059 0.006227
790 POSITIVE REGULATION OF AXON EXTENSION 13 36 0.001059 0.006227
791 OLFACTORY LOBE DEVELOPMENT 13 36 0.001059 0.006227
792 REGULATION OF CATABOLIC PROCESS 136 731 0.001061 0.006236
793 CALCIUM ION TRANSMEMBRANE TRANSPORT 38 159 0.001063 0.006239
794 PEPTIDYL TYROSINE MODIFICATION 43 186 0.001073 0.006288
795 MULTICELLULAR ORGANISM REPRODUCTION 142 768 0.001078 0.006311
796 PLACENTA DEVELOPMENT 34 138 0.001086 0.006351
797 NEGATIVE REGULATION OF CELL GROWTH 40 170 0.001101 0.006427
798 AXON REGENERATION 10 24 0.00112 0.006499
799 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 10 24 0.00112 0.006499
800 RESPONSE TO STEROL 10 24 0.00112 0.006499
801 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 12 32 0.001117 0.006499
802 REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY 10 24 0.00112 0.006499
803 REGULATION OF LEUKOCYTE MIGRATION 36 149 0.001153 0.006679
804 LUNG MORPHOGENESIS 15 45 0.001167 0.006735
805 VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 15 45 0.001167 0.006735
806 EXOCRINE SYSTEM DEVELOPMENT 15 45 0.001167 0.006735
807 LYMPHOCYTE DIFFERENTIATION 47 209 0.001211 0.006983
808 REGULATION OF LIPID METABOLIC PROCESS 60 282 0.00123 0.007082
809 ORGANIC HYDROXY COMPOUND TRANSPORT 37 155 0.001256 0.007214
810 SOMITE DEVELOPMENT 22 78 0.001254 0.007214
811 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 44 193 0.001276 0.007321
812 REGULATION OF CIRCADIAN RHYTHM 27 103 0.001282 0.007337
813 REGULATION OF CALCIUM ION IMPORT 27 103 0.001282 0.007337
814 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 33 134 0.001285 0.007346
815 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 14 41 0.001295 0.007382
816 CELL SUBSTRATE JUNCTION ASSEMBLY 14 41 0.001295 0.007382
817 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 16 50 0.001328 0.007544
818 TUBE FORMATION 32 129 0.001327 0.007544
819 PURINE CONTAINING COMPOUND CATABOLIC PROCESS 16 50 0.001328 0.007544
820 LIPID MODIFICATION 47 210 0.001345 0.007634
821 NEGATIVE REGULATION OF MAPK CASCADE 35 145 0.001362 0.007721
822 HEXOSE TRANSMEMBRANE TRANSPORT 8 17 0.001373 0.007723
823 REGULATION OF ENERGY HOMEOSTASIS 8 17 0.001373 0.007723
824 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 8 17 0.001373 0.007723
825 REGULATION OF CALCINEURIN NFAT SIGNALING CASCADE 8 17 0.001373 0.007723
826 GLUCOSE TRANSMEMBRANE TRANSPORT 8 17 0.001373 0.007723
827 DEFINITIVE HEMOPOIESIS 8 17 0.001373 0.007723
828 POSITIVE REGULATION OF CATION CHANNEL ACTIVITY 13 37 0.001418 0.00793
829 RESPONSE TO NERVE GROWTH FACTOR 13 37 0.001418 0.00793
830 REGULATION OF RECEPTOR INTERNALIZATION 13 37 0.001418 0.00793
831 MYOBLAST DIFFERENTIATION 13 37 0.001418 0.00793
832 REGULATION OF MUSCLE HYPERTROPHY 13 37 0.001418 0.00793
833 RESPONSE TO INSULIN 46 205 0.001421 0.00794
834 NOTCH SIGNALING PATHWAY 29 114 0.00144 0.008037
835 CRANIAL SKELETAL SYSTEM DEVELOPMENT 17 55 0.001464 0.008156
836 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 74 365 0.001494 0.008315
837 PEPTIDYL THREONINE MODIFICATION 15 46 0.001502 0.008351
838 REGULATION OF SYNAPSE ASSEMBLY 22 79 0.001504 0.008354
839 NEURON PROJECTION REGENERATION 12 33 0.001526 0.008454
840 REGULATION OF BONE RESORPTION 12 33 0.001526 0.008454
841 NEURAL TUBE FORMATION 25 94 0.001528 0.008454
842 POSITIVE REGULATION OF CAMP METABOLIC PROCESS 24 89 0.001531 0.008461
843 STEROID HORMONE MEDIATED SIGNALING PATHWAY 31 125 0.001571 0.008672
844 CELLULAR RESPONSE TO OXIDATIVE STRESS 42 184 0.001581 0.008716
845 STEM CELL DIVISION 11 29 0.001604 0.0088
846 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 11 29 0.001604 0.0088
847 REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 11 29 0.001604 0.0088
848 NEUROBLAST PROLIFERATION 11 29 0.001604 0.0088
849 MEMBRANE ASSEMBLY 10 25 0.001627 0.008883
850 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 10 25 0.001627 0.008883
851 REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 25 0.001627 0.008883
852 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 10 25 0.001627 0.008883
853 CELLULAR RESPONSE TO RETINOIC ACID 19 65 0.00166 0.009058
854 NEURAL CREST CELL MIGRATION 16 51 0.001678 0.009144
855 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 14 42 0.001686 0.009176
856 FORMATION OF PRIMARY GERM LAYER 28 110 0.001705 0.009271
857 MUSCLE ORGAN MORPHOGENESIS 20 70 0.001725 0.009364
858 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 32 131 0.001738 0.009424
859 REGULATION OF NEURON DEATH 54 252 0.001773 0.009593
860 LIMBIC SYSTEM DEVELOPMENT 26 100 0.001771 0.009593
861 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 7 14 0.001787 0.009647
862 DETECTION OF CALCIUM ION 7 14 0.001787 0.009647
863 PLATELET ACTIVATION 34 142 0.001829 0.009852
864 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 47 213 0.001829 0.009852
865 GLYCEROLIPID METABOLIC PROCESS 72 356 0.001832 0.009855
NumGOOverlapSizeP ValueAdj. P Value
1 ENZYME BINDING 379 1737 4.534e-18 4.212e-15
2 CALCIUM ION BINDING 182 697 2.174e-16 1.01e-13
3 MOLECULAR FUNCTION REGULATOR 299 1353 4.427e-15 1.371e-12
4 ACTIN BINDING 113 393 1.435e-13 3.334e-11
5 RECEPTOR BINDING 313 1476 2.693e-13 5.004e-11
6 CYTOSKELETAL PROTEIN BINDING 195 819 3.343e-13 5.176e-11
7 GROWTH FACTOR BINDING 49 123 4.806e-12 6.378e-10
8 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 73 228 1.274e-11 1.315e-09
9 MACROMOLECULAR COMPLEX BINDING 292 1399 1.268e-11 1.315e-09
10 PROTEIN DOMAIN SPECIFIC BINDING 151 624 4.82e-11 4.478e-09
11 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 151 629 8.999e-11 7.6e-09
12 CALMODULIN BINDING 60 179 1.061e-10 8.21e-09
13 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 85 303 5.761e-10 4.117e-08
14 KINASE BINDING 141 606 3.486e-09 2.313e-07
15 SMAD BINDING 31 72 4.186e-09 2.43e-07
16 PROTEIN KINASE ACTIVITY 147 640 4.041e-09 2.43e-07
17 KINASE ACTIVITY 183 842 4.891e-09 2.673e-07
18 PROTEIN COMPLEX BINDING 199 935 5.965e-09 3.078e-07
19 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 87 328 7.179e-09 3.51e-07
20 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 32 81 2.953e-08 1.372e-06
21 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 84 329 8.238e-08 3.644e-06
22 CELL ADHESION MOLECULE BINDING 55 186 8.949e-08 3.779e-06
23 ADENYL NUCLEOTIDE BINDING 290 1514 1.352e-07 5.462e-06
24 TRANSMEMBRANE TRANSPORTER ACTIVITY 203 997 1.482e-07 5.543e-06
25 PDZ DOMAIN BINDING 33 90 1.492e-07 5.543e-06
26 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 237 1199 1.656e-07 5.916e-06
27 GTPASE BINDING 76 295 2.275e-07 7.827e-06
28 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 200 992 3.833e-07 1.272e-05
29 SULFUR COMPOUND BINDING 63 234 4.653e-07 1.461e-05
30 RIBONUCLEOTIDE BINDING 343 1860 4.717e-07 1.461e-05
31 GLYCOSAMINOGLYCAN BINDING 57 205 5.166e-07 1.548e-05
32 REGULATORY REGION NUCLEIC ACID BINDING 169 818 6.514e-07 1.891e-05
33 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 78 315 8.793e-07 2.475e-05
34 ION CHANNEL BINDING 36 111 1.333e-06 3.643e-05
35 ENZYME REGULATOR ACTIVITY 191 959 1.644e-06 4.364e-05
36 COLLAGEN BINDING 25 65 1.694e-06 4.371e-05
37 INTEGRIN BINDING 34 105 2.701e-06 6.783e-05
38 ENZYME ACTIVATOR ACTIVITY 105 471 2.875e-06 7.029e-05
39 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 95 417 3.233e-06 7.701e-05
40 RECEPTOR SIGNALING PROTEIN ACTIVITY 48 172 3.541e-06 8.224e-05
41 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 24 64 4.58e-06 0.0001038
42 ZINC ION BINDING 221 1155 4.957e-06 0.0001071
43 TRANSPORTER ACTIVITY 241 1276 4.886e-06 0.0001071
44 TRANSCRIPTION FACTOR BINDING 113 524 6.348e-06 0.000134
45 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 58 226 6.657e-06 0.0001374
46 HEPARIN BINDING 44 157 7.864e-06 0.0001588
47 BETA CATENIN BINDING 28 84 1.079e-05 0.0002133
48 LIPID BINDING 135 657 1.151e-05 0.0002228
49 ACTIN FILAMENT BINDING 36 121 1.22e-05 0.0002312
50 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 101 464 1.287e-05 0.0002391
51 VOLTAGE GATED ION CHANNEL ACTIVITY 50 190 1.346e-05 0.0002451
52 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 10 16 1.389e-05 0.0002482
53 TRANSITION METAL ION BINDING 258 1400 1.477e-05 0.0002562
54 PHOSPHOLIPID BINDING 82 360 1.489e-05 0.0002562
55 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 29 90 1.586e-05 0.0002679
56 PHOSPHOLIPID TRANSPORTER ACTIVITY 19 48 1.811e-05 0.0003005
57 RHO GTPASE BINDING 26 78 2.2e-05 0.0003586
58 CAMP BINDING 12 23 2.374e-05 0.0003802
59 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 24 70 2.659e-05 0.0004187
60 CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 127 622 2.821e-05 0.0004367
61 PHOSPHORIC DIESTER HYDROLASE ACTIVITY 28 90 4.517e-05 0.0006879
62 PROTEIN SERINE THREONINE KINASE ACTIVITY 95 445 5.05e-05 0.0007567
63 HISTONE ACETYLTRANSFERASE BINDING 13 28 5.315e-05 0.0007837
64 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 9 15 6.065e-05 0.0008668
65 PROTEIN KINASE A CATALYTIC SUBUNIT BINDING 9 15 6.065e-05 0.0008668
66 CYCLIC NUCLEOTIDE BINDING 15 36 6.794e-05 0.0009562
67 CHANNEL REGULATOR ACTIVITY 36 131 7.903e-05 0.001096
68 ACTIVATING TRANSCRIPTION FACTOR BINDING 20 57 8.438e-05 0.001153
69 IDENTICAL PROTEIN BINDING 221 1209 0.0001023 0.001378
70 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 43 168 0.0001045 0.001387
71 PHOSPHATIDYLINOSITOL BINDING 49 200 0.0001171 0.001533
72 LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 8 13 0.000125 0.001613
73 CATION CHANNEL ACTIVITY 67 298 0.0001298 0.001652
74 PROTEIN KINASE A BINDING 16 42 0.0001408 0.001768
75 R SMAD BINDING 11 23 0.0001447 0.001782
76 STEROID HORMONE RECEPTOR ACTIVITY 20 59 0.0001458 0.001782
77 PROTEIN TYROSINE KINASE ACTIVITY 44 176 0.0001563 0.001886
78 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 117 588 0.0001744 0.002051
79 PHOSPHATASE REGULATOR ACTIVITY 26 87 0.0001738 0.002051
80 DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 42 167 0.0001894 0.0022
81 TRANSLATION REGULATOR ACTIVITY 14 35 0.0001994 0.002288
82 GATED CHANNEL ACTIVITY 71 325 0.0002092 0.00237
83 DOUBLE STRANDED DNA BINDING 146 764 0.0002129 0.002383
84 INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 106 527 0.0002272 0.002513
85 ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 65 293 0.0002418 0.002643
86 PHOSPHORIC ESTER HYDROLASE ACTIVITY 78 368 0.0002874 0.003069
87 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 29 104 0.0002865 0.003069
88 PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY 10 21 0.0003051 0.00322
89 ATPASE ACTIVITY 88 427 0.0003288 0.003432
90 STEROID HORMONE RECEPTOR BINDING 24 81 0.0003502 0.003615
91 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 11 25 0.0003606 0.003681
92 ACTININ BINDING 12 29 0.000391 0.003948
93 ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES 32 121 0.0004076 0.003986
94 RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 23 77 0.0004054 0.003986
95 GLYCOPROTEIN BINDING 28 101 0.0004012 0.003986
96 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 17 50 0.0004319 0.004179
97 RECEPTOR SERINE THREONINE KINASE BINDING 8 15 0.0004763 0.004515
98 POTASSIUM CHANNEL REGULATOR ACTIVITY 16 46 0.0004731 0.004515
99 CYCLASE ACTIVITY 10 22 0.0004869 0.004523
100 WNT ACTIVATED RECEPTOR ACTIVITY 10 22 0.0004869 0.004523
101 PHOSPHOLIPASE BINDING 9 19 0.0006456 0.005939
102 TRANSCRIPTION COREPRESSOR ACTIVITY 50 221 0.0007489 0.006821
103 WNT PROTEIN BINDING 12 31 0.0008031 0.007244
104 TRANSFORMING GROWTH FACTOR BETA BINDING 8 16 0.0008319 0.007291
105 BINDING BRIDGING 41 173 0.0008272 0.007291
106 LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY 8 16 0.0008319 0.007291
107 CARBOHYDRATE TRANSPORTER ACTIVITY 15 44 0.0008964 0.007783
108 MONOSACCHARIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 20 0.001024 0.008646
109 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 9 20 0.001024 0.008646
110 TRANSLATION REPRESSOR ACTIVITY 9 20 0.001024 0.008646
111 RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 13 36 0.001059 0.00886
112 SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY 12 32 0.001117 0.009184
113 RECEPTOR ACTIVATOR ACTIVITY 12 32 0.001117 0.009184
114 SCAFFOLD PROTEIN BINDING 15 45 0.001167 0.009507
115 G PROTEIN COUPLED RECEPTOR BINDING 56 259 0.001189 0.009604
NumGOOverlapSizeP ValueAdj. P Value
1 CELL PROJECTION 406 1786 8.717e-23 5.091e-20
2 CELL JUNCTION 285 1151 1.723e-21 5.032e-19
3 MEMBRANE REGION 280 1134 6.236e-21 1.214e-18
4 NEURON PROJECTION 237 942 7.077e-19 1.033e-16
5 SYNAPSE 198 754 5.023e-18 5.867e-16
6 NEURON PART 294 1265 6.542e-18 6.368e-16
7 INTRINSIC COMPONENT OF PLASMA MEMBRANE 351 1649 4.341e-15 3.169e-13
8 MEMBRANE MICRODOMAIN 94 288 3.882e-15 3.169e-13
9 PLASMA MEMBRANE REGION 220 929 1.691e-14 1.097e-12
10 PROTEINACEOUS EXTRACELLULAR MATRIX 107 356 2.674e-14 1.562e-12
11 EXTRACELLULAR MATRIX 119 426 2.928e-13 1.555e-11
12 CELL SURFACE 183 757 4.395e-13 2.139e-11
13 GOLGI APPARATUS 304 1445 1.699e-12 7.631e-11
14 SOMATODENDRITIC COMPARTMENT 160 650 2.971e-12 1.24e-10
15 ANCHORING JUNCTION 128 489 5.723e-12 2.228e-10
16 CELL SUBSTRATE JUNCTION 109 398 1.126e-11 4.109e-10
17 SYNAPSE PART 149 610 3.123e-11 1.073e-09
18 DENDRITE 118 451 3.995e-11 1.296e-09
19 CELL LEADING EDGE 97 350 7.481e-11 2.299e-09
20 CELL PROJECTION PART 208 946 1.438e-10 4.2e-09
21 AXON 109 418 2.74e-10 7.621e-09
22 POSTSYNAPSE 101 378 2.906e-10 7.715e-09
23 EXCITATORY SYNAPSE 63 197 3.344e-10 8.492e-09
24 EXTRACELLULAR MATRIX COMPONENT 46 125 4.976e-10 1.211e-08
25 ACTIN CYTOSKELETON 113 444 6.158e-10 1.439e-08
26 CELL CELL JUNCTION 100 383 1.384e-09 3.108e-08
27 PLASMA MEMBRANE PROTEIN COMPLEX 123 510 3.79e-09 8.198e-08
28 BASEMENT MEMBRANE 35 93 2.939e-08 6.131e-07
29 INTRACELLULAR VESICLE 251 1259 3.237e-08 6.519e-07
30 ENDOPLASMIC RETICULUM 311 1631 7.133e-08 1.389e-06
31 LAMELLIPODIUM 52 172 9.049e-08 1.705e-06
32 GOLGI APPARATUS PART 185 893 1.567e-07 2.772e-06
33 PLASMA MEMBRANE RAFT 32 86 1.546e-07 2.772e-06
34 CELL BODY 114 494 1.735e-07 2.98e-06
35 SARCOLEMMA 41 125 1.794e-07 2.993e-06
36 APICAL PART OF CELL 89 361 1.892e-07 3.069e-06
37 CYTOSKELETON 362 1967 2.678e-07 4.227e-06
38 APICAL JUNCTION COMPLEX 41 128 3.69e-07 5.671e-06
39 CELL CORTEX 64 238 3.966e-07 5.939e-06
40 RECEPTOR COMPLEX 81 327 5.38e-07 7.854e-06
41 CATION CHANNEL COMPLEX 49 167 5.697e-07 8.114e-06
42 CYTOPLASMIC REGION 73 287 6.62e-07 8.992e-06
43 APICAL PLASMA MEMBRANE 74 292 6.478e-07 8.992e-06
44 I BAND 38 121 1.678e-06 2.227e-05
45 AXON PART 58 219 2.308e-06 2.996e-05
46 GOLGI MEMBRANE 146 703 2.792e-06 3.545e-05
47 CELL CORTEX PART 37 119 2.98e-06 3.703e-05
48 PERINUCLEAR REGION OF CYTOPLASM 135 642 3.368e-06 4.098e-05
49 NEURON SPINE 37 121 4.609e-06 5.494e-05
50 BASOLATERAL PLASMA MEMBRANE 55 211 6.955e-06 7.965e-05
51 GLYCOPROTEIN COMPLEX 12 21 6.85e-06 7.965e-05
52 ACTIN BASED CELL PROJECTION 49 181 7.104e-06 7.979e-05
53 CYTOPLASMIC VESICLE PART 126 601 8.253e-06 9.094e-05
54 SITE OF POLARIZED GROWTH 42 149 1.071e-05 0.0001158
55 FILOPODIUM 30 94 1.409e-05 0.0001497
56 CONTRACTILE FIBER 54 211 1.482e-05 0.0001546
57 ENDOSOME 157 793 1.938e-05 0.0001986
58 T TUBULE 18 45 2.532e-05 0.0002549
59 EXTRINSIC COMPONENT OF MEMBRANE 61 252 2.729e-05 0.0002701
60 PLATELET ALPHA GRANULE 25 75 3.144e-05 0.000306
61 SIDE OF MEMBRANE 92 428 5.047e-05 0.0004832
62 EXTRACELLULAR SPACE 249 1376 7.385e-05 0.0006956
63 VACUOLE 217 1180 8.19e-05 0.0007553
64 ACTIN FILAMENT 23 70 8.277e-05 0.0007553
65 PROTEIN KINASE COMPLEX 27 90 0.0001225 0.001101
66 DENSE CORE GRANULE 8 13 0.000125 0.001106
67 CYTOPLASMIC SIDE OF MEMBRANE 43 170 0.0001394 0.001215
68 PLATELET ALPHA GRANULE LUMEN 19 55 0.0001597 0.001371
69 ENDOPLASMIC RETICULUM PART 212 1163 0.0001666 0.00141
70 CELL CELL CONTACT ZONE 21 64 0.0001698 0.001411
71 RUFFLE 40 156 0.0001715 0.001411
72 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 28 98 0.0002325 0.001885
73 TRANSPORTER COMPLEX 70 321 0.000244 0.001952
74 PHOSPHATASE COMPLEX 17 48 0.000248 0.001957
75 WNT SIGNALOSOME 7 11 0.0002565 0.001998
76 ACTIN FILAMENT BUNDLE 19 57 0.0002715 0.002087
77 NEURON PROJECTION TERMINUS 34 129 0.0002932 0.002224
78 ACTOMYOSIN 20 62 0.000311 0.002329
79 POTASSIUM CHANNEL COMPLEX 26 90 0.000316 0.002336
80 COATED PIT 21 67 0.0003468 0.002464
81 CORTICAL CYTOSKELETON 24 81 0.0003502 0.002464
82 CORTICAL ACTIN CYTOSKELETON 19 58 0.0003496 0.002464
83 MAIN AXON 19 58 0.0003496 0.002464
84 VESICLE MEMBRANE 102 512 0.0004214 0.002901
85 POSTSYNAPTIC MEMBRANE 48 205 0.0004222 0.002901
86 SYNAPTIC MEMBRANE 58 261 0.000484 0.003287
87 INTERCALATED DISC 17 51 0.0005613 0.003725
88 BASAL PART OF CELL 17 51 0.0005613 0.003725
89 SECRETORY VESICLE 92 461 0.0007408 0.004861
90 COMPLEX OF COLLAGEN TRIMERS 10 23 0.0007502 0.004868
91 PRESYNAPSE 61 283 0.0008032 0.005155
92 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 34 136 0.0008261 0.005244
93 SECRETORY GRANULE 73 352 0.0008427 0.005291
94 ENDOCYTIC VESICLE 56 256 0.0008919 0.005462
95 MICROTUBULE 82 405 0.0008979 0.005462
96 NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK 181 1005 0.0008885 0.005462
97 NEURONAL POSTSYNAPTIC DENSITY 17 53 0.0009221 0.005552
98 FILAMENTOUS ACTIN 9 20 0.001024 0.0061
99 CELL PROJECTION MEMBRANE 63 298 0.001118 0.006594
100 COLLAGEN TRIMER 24 88 0.001293 0.00755
101 ENDOSOMAL PART 85 430 0.001539 0.008897

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 MAPK_signaling_pathway_hsa04010 88 295 8.255e-12 3.681e-10
2 cGMP_PKG_signaling_pathway_hsa04022 58 163 1.416e-11 3.681e-10
3 Wnt_signaling_pathway_hsa04310 50 146 1.619e-09 2.806e-08
4 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 48 139 2.493e-09 3.241e-08
5 Hippo_signaling_pathway_hsa04390 51 154 4.154e-09 4.321e-08
6 PI3K_Akt_signaling_pathway_hsa04151 92 352 5.918e-09 5.129e-08
7 Adherens_junction_hsa04520 30 72 1.866e-08 1.386e-07
8 Calcium_signaling_pathway_hsa04020 55 182 3.96e-08 2.574e-07
9 Focal_adhesion_hsa04510 58 199 7.061e-08 4.08e-07
10 TGF_beta_signaling_pathway_hsa04350 31 84 2.979e-07 1.549e-06
11 AMPK_signaling_pathway_hsa04152 39 121 5.886e-07 2.663e-06
12 Rap1_signaling_pathway_hsa04015 57 206 6.146e-07 2.663e-06
13 Ras_signaling_pathway_hsa04014 62 232 7.539e-07 2.911e-06
14 Sphingolipid_signaling_pathway_hsa04071 38 118 8.37e-07 2.911e-06
15 cAMP_signaling_pathway_hsa04024 55 198 8.396e-07 2.911e-06
16 Tight_junction_hsa04530 49 170 1.015e-06 3.3e-06
17 Gap_junction_hsa04540 30 88 3.151e-06 9.638e-06
18 Cellular_senescence_hsa04218 45 160 5.633e-06 1.627e-05
19 Apelin_signaling_pathway_hsa04371 40 137 6.836e-06 1.871e-05
20 FoxO_signaling_pathway_hsa04068 37 132 3.988e-05 0.0001037
21 Oocyte_meiosis_hsa04114 35 124 5.442e-05 0.0001347
22 ECM_receptor_interaction_hsa04512 26 82 5.824e-05 0.0001377
23 Phospholipase_D_signaling_pathway_hsa04072 39 146 8.031e-05 0.0001816
24 HIF_1_signaling_pathway_hsa04066 29 100 0.0001363 0.0002953
25 Hedgehog_signaling_pathway_hsa04340 17 47 0.0001849 0.0003847
26 mTOR_signaling_pathway_hsa04150 38 151 0.0003682 0.0007363
27 Regulation_of_actin_cytoskeleton_hsa04810 46 208 0.001937 0.003731
28 ErbB_signaling_pathway_hsa04012 22 85 0.004075 0.007569
29 Cell_adhesion_molecules_.CAMs._hsa04514 32 145 0.008932 0.01602
30 ABC_transporters_hsa02010 13 45 0.009501 0.01647
31 Phosphatidylinositol_signaling_system_hsa04070 22 99 0.02486 0.04169
32 p53_signaling_pathway_hsa04115 16 68 0.03136 0.05095
33 VEGF_signaling_pathway_hsa04370 14 59 0.0396 0.06241
34 Hippo_signaling_pathway_multiple_species_hsa04392 8 29 0.04914 0.07516
35 Cell_cycle_hsa04110 25 124 0.05184 0.07702
36 Endocytosis_hsa04144 44 244 0.07108 0.1027
37 Notch_signaling_pathway_hsa04330 11 48 0.07851 0.1103
38 Jak_STAT_signaling_pathway_hsa04630 30 162 0.09135 0.125
39 TNF_signaling_pathway_hsa04668 21 108 0.09513 0.1268
40 Mitophagy_animal_hsa04137 13 65 0.1393 0.181
41 Peroxisome_hsa04146 15 83 0.2153 0.2715
42 Cytokine_cytokine_receptor_interaction_hsa04060 44 270 0.2205 0.2715
43 Autophagy_animal_hsa04140 22 128 0.2245 0.2715
44 Apoptosis_hsa04210 23 138 0.2659 0.3142
45 Phagosome_hsa04145 24 152 0.3576 0.4132
46 Autophagy_other_hsa04136 5 32 0.503 0.5686
47 Ferroptosis_hsa04216 6 40 0.5315 0.5881
48 Necroptosis_hsa04217 22 164 0.6859 0.7431
49 Lysosome_hsa04142 16 123 0.718 0.7534
50 Apoptosis_multiple_species_hsa04215 4 33 0.7245 0.7534
51 NF_kappa_B_signaling_pathway_hsa04064 10 95 0.8981 0.9157
52 Neuroactive_ligand_receptor_interaction_hsa04080 32 278 0.9377 0.9377

Quest ID: 47c810eee875496a587ef7271d3017d8